<SEC-DOCUMENT>0001193125-21-288885.txt : 20211001
<SEC-HEADER>0001193125-21-288885.hdr.sgml : 20211001
<ACCEPTANCE-DATETIME>20211001081206
ACCESSION NUMBER:		0001193125-21-288885
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20210928
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211001
DATE AS OF CHANGE:		20211001

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Roivant Sciences Ltd.
		CENTRAL INDEX KEY:			0001635088
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				981173944
		STATE OF INCORPORATION:			D0
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40782
		FILM NUMBER:		211297164

	BUSINESS ADDRESS:	
		STREET 1:		CLARENDON HOUSE, 2 CHURCH STREET
		CITY:			HAMILTON HM11
		STATE:			D0
		ZIP:			HM11
		BUSINESS PHONE:		441-295-5950

	MAIL ADDRESS:	
		STREET 1:		CLARENDON HOUSE
		STREET 2:		2 CHURCH STREET
		CITY:			HAMILTON
		STATE:			D0
		ZIP:			HM11
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d230641d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ck0001635088="http://roivant.com/20210928" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>Form 8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2021-09-28_to_2021-09-28">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2021-09-28_to_2021-09-28">0001635088</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_CurrentFiscalYearEndDate_duration_2021-09-28_to_2021-09-28" name="dei:CurrentFiscalYearEndDate" contextRef="duration_2021-09-28_to_2021-09-28">--03-31</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="ck0001635088-20210928.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2021-09-28_to_2021-09-28"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001635088</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-09-28</xbrli:startDate> <xbrli:endDate>2021-09-28</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2021-09-28_to_2021-09-28_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001635088</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-09-28</xbrli:startDate> <xbrli:endDate>2021-09-28</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2021-09-28_to_2021-09-28_us-gaap-StatementClassOfStockAxis_us-gaap-WarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001635088</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-09-28</xbrli:startDate> <xbrli:endDate>2021-09-28</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, DC 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2021-09-28_to_2021-09-28">8-K</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2021-09-28_to_2021-09-28" format="ixt:datemonthdayyearen">September&#160;28, 2021</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2021-09-28_to_2021-09-28">Roivant Sciences Ltd.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2021-09-28_to_2021-09-28" format="ixt-sec:edgarprovcountryen">Bermuda</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2021-09-28_to_2021-09-28">001-40782</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2021-09-28_to_2021-09-28">98-1173944</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2021-09-28_to_2021-09-28">Suite 1</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2021-09-28_to_2021-09-28">3rd Floor</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine3" contextRef="duration_2021-09-28_to_2021-09-28">11-12 St. James&#8217;s Square</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2021-09-28_to_2021-09-28">London</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2021-09-28_to_2021-09-28">SW1Y 4LB</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCountry" contextRef="duration_2021-09-28_to_2021-09-28" format="ixt-sec:countrynameen">United Kingdom</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices, and Zip Code)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">+<ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2021-09-28_to_2021-09-28">44 207</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2021-09-28_to_2021-09-28">400 3347</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area Code</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="font-style:italic">see</span> General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2021-09-28_to_2021-09-28" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2021-09-28_to_2021-09-28" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2021-09-28_to_2021-09-28" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2021-09-28_to_2021-09-28" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2021-09-28_to_2021-09-28_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">Common Shares, $0.0000000341740141 par value per share</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2021-09-28_to_2021-09-28_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">ROIV</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2021-09-28_to_2021-09-28_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2021-09-28_to_2021-09-28_us-gaap-StatementClassOfStockAxis_us-gaap-WarrantMember">Redeemable warrants, each whole warrant exercisable for one Common Share</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2021-09-28_to_2021-09-28_us-gaap-StatementClassOfStockAxis_us-gaap-WarrantMember">ROIVW</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2021-09-28_to_2021-09-28_us-gaap-StatementClassOfStockAxis_us-gaap-WarrantMember" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2 of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2021-09-28_to_2021-09-28" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2021-09-28_to_2021-09-28" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">INTRODUCTORY NOTE </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&#160;30, 2021, Roivant Sciences Ltd. (&#8220;Roivant&#8221; or the &#8220;Company&#8221;) completed its previously announced business combination (the &#8220;Business Combination&#8221;) with Montes Archimedes Acquisition Corp. (&#8220;MAAC&#8221;), through the merger of Roivant&#8217;s wholly-owned subsidiary, Rhine Merger Sub, Inc. with MAAC, with MAAC surviving the Business Combination as a wholly owned subsidiary of Roivant. On October&#160;1, 2021, Roivant&#8217;s common shares, $0.0000000341740141 par value per share (the &#8220;Common Shares&#8221;), and warrants are expected to commence trading on The Nasdaq Global Market under the symbols &#8220;ROIV&#8221; and &#8220;ROIVW,&#8221; respectively. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;1.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&#160;30, 2021, Roivant, MAAC, Patient Square Capital LLC, a Delaware limited liability company (&#8220;MAAC Sponsor&#8221;) and the other parties thereto entered into an amendment (&#8220;Amendment No.&#160;2&#8221;) to the Sponsor Support Agreement, dated as of May&#160;1, 2021, as amended by Amendment No.&#160;1 thereto, dated as of June&#160;9, 2021 (as amended, the &#8220;Sponsor Support Agreement&#8221;), to (i)&#160;amend and specify the number of Common Shares that constitute &#8220;20% <span style="white-space:nowrap">Earn-Out</span> Shares,&#8221; &#8220;10% <span style="white-space:nowrap">Earn-Out</span> Shares&#8221; and &#8220;Retained Shares&#8221; for purposes of the Sponsor Support Agreement and (ii)&#160;amend the commencement date of the time period during which the <span style="white-space:nowrap">Earn-Out</span> Shares (as defined in the Sponsor Support Agreement) may vest and become free of the restrictions set forth in Section&#160;2(b) of the Sponsor Support Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description is qualified in its entirety by the text of Amendment No.&#160;2, which is included as Exhibit 10.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;3.02.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Unregistered Sales of Equity Securities </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to the consummation of the Business Combination, MAAC and Roivant entered into subscription agreements (collectively, the &#8220;Subscription Agreements&#8221;) with certain institutional and accredited investors, pursuant to which such investors agreed to subscribe for and purchase, and MAAC agreed to issue and sell to such investors, prior to and substantially concurrently with the closing of the Business Combination, an aggregate of 22,000,000 shares of MAAC Class&#160;A common stock at a purchase price of $10.00 per share, for aggregate gross proceeds of $220,000,000 (the &#8220;PIPE Financing&#8221;). The PIPE Financing was consummated substantially concurrently with the closing of the Business Combination. Each share of MAAC Class&#160;A common stock issued in the PIPE Financing was converted into one Common Share in connection with the closing of the Business Combination. The issuance of the Common Shares pursuant to the PIPE Financing was not registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and the Common Shares were issued in reliance upon the exemption provided in Section&#160;4(a)(2) of the Securities Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description is qualified in its entirety by reference to the Subscription Agreements, the form of which is included as Exhibit 10.2 to this Current Report and is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;3.03.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Material Modification to Rights of Security Holders. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information set forth in Item 5.03 is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&#160;28, 2021 (the &#8220;Effective Date&#8221;), the Company appointed Richard Pulik as Principal Financial Officer of the Company and as Chief Financial Officer of the Company&#8217;s subsidiary, Roivant Sciences, Inc. (&#8220;RSI&#8221;). Matthew Gline, who has been serving as Principal Financial Officer of the Company and Chief Financial Officer of RSI, will step down from those positions as of the Effective Date. Mr.&#160;Gline will continue to serve as Principal Executive Officer of the Company and Chief Executive Officer of RSI. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Pulik brings over twenty years of experience in the biopharmaceutical industry and finance. Prior to joining the Company, Mr.&#160;Pulik was the Global Head of Business Development&#160;&amp; Licensing and Portfolio Management, Oncology at Novartis and a member of Novartis&#8217;s Innovation Management Board and the Novartis Oncology Leadership Team, from August 2019 to September 2021. Mr.&#160;Pulik joined Novartis in 2012 as a Senior Director, Mergers&#160;&amp; Acquisitions based in Basel, Switzerland working on the strategy and execution of the deals that shaped Novartis. In 2015, Mr.&#160;Pulik was appointed as Vice President, Head of North America Investor Relations for Novartis. Prior to these roles at Novartis, Mr.&#160;Pulik worked at Bank of America Merrill Lynch, Monitor Group and UBS Investment Bank, focusing on mergers and acquisitions and strategy in the healthcare sector. Mr.&#160;Pulik received a B.S. in Finance from The Wharton School and a B.A. in Economics and International Relations at the University of Pennsylvania in 2001. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with Mr.&#160;Pulik&#8217;s appointment as Chief Financial Officer of RSI, the parties entered into an employment agreement (the &#8220;Employment Agreement&#8221;). Pursuant to the terms of the Employment Agreement, Mr.&#160;Pulik will receive an annual base salary of $400,000, which is subject to adjustment at the discretion of the compensation committee (the &#8220;Compensation Committee&#8221;) of the Company&#8217;s board of directors, and is eligible to receive a discretionary annual performance bonus, with a target annual value equal to 100% of his base salary based on an assessment by the Compensation Committee of his performance, as well as business conditions at the Company. Mr.&#160;Pulik received a grant (the &#8220;RSU Grant&#8221;) of 75,188 restricted stock units (&#8220;RSUs&#8221;) under the Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan (the &#8220;2015 Plan&#8221;) on the Effective Date. At closing of the business combination between the Company and Montes Archimedes Acquisition Corp., the number of RSUs subject to the RSU Grant was adjusted to 220,015 RSUs, as part of the share subdivision applied to all <span style="white-space:nowrap">pre-closing</span> Company common shares and equity incentive awards. Mr.&#160;Pulik will also receive a grant of stock options (the &#8220;Option Grant&#8221;) to purchase 313,419 shares of the Company&#8217;s common stock under the Roivant Sciences Ltd. 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;). The equity awards underlying the RSU Grant and the Option Grant will vest (i) 25% on the first anniversary of the Effective Date and (ii) 75% in equal quarterly installments thereafter over a three-year period, unless Mr.&#160;Pulik is terminated without &#8220;cause&#8221; (as defined in the Employment Agreement) within 12 months following a &#8220;change in control&#8221; (as defined in the 2015 Plan with respect to the RSU Grant and the 2021 Plan with respect to the Option Grant), in which case the RSU Grant and the Option Grant will immediately become fully vested. The Employment Agreement also provides for Mr.&#160;Pulik&#8217;s eligibility to receive additional discretionary periodic or annual equity incentive awards and participation in the Company&#8217;s employee benefits plans and programs and his execution of the Company&#8217;s standard Employee <span style="white-space:nowrap">Non-Disclosure,</span> Invention Assignment and Restrictive Covenant Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the Employment Agreement, in the event Mr.&#160;Pulik&#8217;s employment is terminated without &#8220;cause&#8221; (other than due to Mr.&#160;Pulik&#8217;s death or &#8220;disability&#8221;) or Mr.&#160;Pulik resigns for &#8220;good reason&#8221; (each as defined in the Employment Agreement), then, subject to Mr.&#160;Pulik&#8217;s timely execution and <span style="white-space:nowrap">non-revocation</span> of a release of claims and continued compliance with applicable restrictive covenants, Mr.&#160;Pulik will be entitled to receive (i)&#160;continued payment of his base salary for six months following the date of his termination, payable in accordance with customary payroll procedures, (ii)&#160;an amount equal to 50% of his target annual bonus for the year of termination, payable in six equal monthly installments following the date of his termination and (iii)&#160;monthly reimbursement of COBRA premiums (less active employee rates) for 6 months following the date of his termination (or, if earlier, until the date Mr.&#160;Pulik becomes eligible for coverage under a subsequent employer&#8217;s group health insurance plan). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Employment Agreement is a summary only and is qualified in its entirety by reference to the full text of the Employment Agreement. A copy of the Employment Agreement will be filed as an exhibit to the Company&#8217;s quarterly report on Form <span style="white-space:nowrap">10-Q</span> for the fiscal quarter ending September&#160;30, 2021. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no family relationships between Mr.&#160;Pulik and any director or executive officer of the Company or its subsidiaries. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.03.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&#160;30, 2021, Roivant amended and restated its <span style="white-space:nowrap">bye-laws</span> (the &#8220;A&amp;R <span style="white-space:nowrap">Bye-laws&#8221;)</span> in connection with the closing of the Business Combination. The A&amp;R <span style="white-space:nowrap">Bye-laws</span> are included as Exhibit 3.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and are incorporated herein by reference. The terms of the A&amp;R <span style="white-space:nowrap">Bye-laws</span> are substantially the same as the terms set forth in the form previously filed as Exhibit 3.2 to Roivant&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-4,</span> initially filed on May&#160;14, 2021. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;8.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October&#160;1, 2021, Roivant and MAAC issued a press release relating to the completion of the Business Combination and the expected commencement of trading of Roivant&#8217;s securities on The Nasdaq Global Market. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K.</span> </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br />No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description of Exhibit</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;3.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d230641dex31.htm">Amended and Restated <span style="white-space:nowrap">Bye-laws</span> of Roivant Sciences Ltd. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d230641dex101.htm">Amendment No.&#160;2 to the Sponsor Support Agreement, dated as of September&#160;30, 2021, among Roivant, MAAC, MAAC Sponsor and the other parties thereto </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/1635088/000119312521162191/d65062ds4.htm#rom65062_40">Form of Subscription Agreement (incorporated by reference to Annex B of the joint proxy statement/prospectus which is part of Roivant&#8217;s registration statement on Form <span style="white-space:nowrap">S-4,</span> initially filed on May&#160;14, 2021) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d230641dex991.htm">Roivant Sciences Ltd. Press Release, dated October&#160;1, 2021 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded with Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0">


<tr>

<td style="width:13%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:86%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">ROIVANT SCIENCES LTD.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Marianne Romeo</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Marianne Romeo</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Head, Global Transactions&#160;&amp; Risk Management</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: October&#160;1, 2021 </p>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>d230641dex31.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED BYE-LAWS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ROIVANT SCIENCES
LTD. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Adopted on September&nbsp;30, 2021 </P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><U>TABLE OF CONTENTS </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>INTERPRETATION</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>4</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Definitions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>SHARES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>7</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Power to Issue Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Power of the Company to Purchase its Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rights Attaching to Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Lock-Up</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Calls on Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeiture of Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Share Certificates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fractional Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>REGISTRATION OF SHARES</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>13</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Register of Members</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Registered Holder Absolute Owner</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer of Registered Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transmission of Registered Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ALTERATION OF SHARE CAPITAL</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>16</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Power to Alter Capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Variation of Rights Attaching to Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>DIVIDENDS AND CAPITALIZATION</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>16</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">16.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividends</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">17.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Power to Set Aside Profits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">18.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Method of Payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">19.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>MEETINGS OF MEMBERS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>18</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">20.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual General Meetings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">21.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Special General Meetings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">22.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Requisitioned General Meetings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">23.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">24.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Giving Notice and Access</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">25.&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Postponement or Cancellation of General Meeting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">26.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice of Nominations and Member Business</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">27.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Electronic Participation and Security at General Meetings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">28.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Quorum at General Meetings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chairperson to Preside at General Meetings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">30.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Voting on Resolutions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">31.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Power to Demand a Vote on a Poll</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">32.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Voting by Joint Holders of Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">33.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Instrument of Proxy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">34.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Representation of Corporate Member</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">35.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjournment of General Meeting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">36.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Written Resolutions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">37.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Directors Attendance at General Meetings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>DIRECTORS AND OFFICERS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>28</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">38.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Election of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">39.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Number of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">40.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Classes of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">41.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Term of Office of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">42.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alternate Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">43.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Removal of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">44.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vacancy in the Office of Director</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">45.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Remuneration of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">46.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Directors to Manage Business</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">47.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Powers of the Board of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">48.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Register of Directors and Officers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">49.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Appointment of Officers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">50.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Appointment of Secretary</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">51.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Duties of Officers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">52.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Remuneration of Officers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">53.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conflicts of Interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">54.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate Opportunities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">55.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indemnification and Exculpation of Directors and Officers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>MEETINGS OF THE BOARD OF DIRECTORS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>34</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">56.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Board Meetings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">57.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Notice of Board Meetings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">58.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Electronic Participation in Meetings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">59.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Quorum at Board Meetings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">60.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chairperson to Preside</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">61.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Written Resolutions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">62.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Validity of Prior Acts of the Board</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>CORPORATE RECORDS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>36</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">63.&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Minutes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">64.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate Records</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">65.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Form and Use of Seal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ACCOUNTS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>36</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">66.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Records of Account</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">67.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial Year End</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>AUDITS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>37</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">68.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual Audit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">69.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Appointment of Auditor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">70.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Remuneration of Auditor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">71.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Duties of Auditor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">72.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Access to Records</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">73.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial Statements and the Auditor&#146;s Report</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">74.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vacancy in the Office of Auditor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>BUSINESS COMBINATIONS</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>38</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">75.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Business Combinations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>VOLUNTARY <FONT STYLE="white-space:nowrap">WINDING-UP</FONT> AND
DISSOLUTION</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>43</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">76.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Winding-Up</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>CHANGES TO CONSTITUTION</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>43</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">77.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes to <FONT STYLE="white-space:nowrap">Bye-laws</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">78.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes to the Memorandum of Association</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">79.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Discontinuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">80.&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amalgamation or Merger</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INTERPRETATION </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Definitions </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In these Bye-laws (the &#147;<B>Bye-laws</B>&#148;), the following words and expressions shall, where not
inconsistent with the context, have the following meanings, respectively: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Act</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Companies Act 1981 (as amended);</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Affiliate</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">as applied to any Person, means any other Person that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with such Person, including, without limitation, any general
partner, managing member, officer or director of such Person or any venture capital, private equity or other investment fund or account now or hereafter existing that is controlled by one or more general partners or managing members of, or shares
the same management company or investment advisor with, such Person, and the term &#147;Affiliated&#148; shall have the correlative meaning. The term &#147;control&#148; means the possession, directly or indirectly, of the power to direct or cause
the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Appointed Stock Exchange</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">means an appointed stock exchange as defined under the Act;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Auditor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">any independent auditor that may be appointed pursuant to these Bye-laws and includes an individual, company or partnership;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Board</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the board of directors appointed or elected pursuant to these Bye-laws and acting by resolution in accordance with the Act and these Bye-laws or the directors present at a meeting of directors at which there is a quorum;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Business Day</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">any day other than a Saturday and Sunday on which banks are open for business in New York, New York, London, the United Kingdom and Bermuda;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Common Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">has the meaning given to that term in Bye-law 4;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Roivant Sciences Ltd., an exempted limited company, registered in Bermuda under number 48931, being the company for which these Bye-laws are approved and confirmed;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">a director of the Company;</TD></TR></TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
<DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exchange Act</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Securities Exchange Act of 1934, as amended;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Members</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Persons registered in the Register of Members as the holder of shares in the Company and, when two or more Persons are so registered as joint holders of shares, means the Person whose name stands first in the Register of Members as
one of such joint holders or all of such Persons, as the context so requires;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Memorandum</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Memorandum of Association of the Company;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">written notice as further provided in these Bye-laws unless otherwise specifically stated;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Officer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">any person appointed by the Board to hold an office in the Company;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Permitted Transferee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">means: (A) the Member&#146;s immediate family (which shall mean, with respect to any natural person, any of the following: such person&#146;s spouse or domestic partner, the siblings of such person and his or her spouse or domestic
partner, and the direct descendants and ascendants (including adopted and step children and parents) of such person and his or her spouses or domestic partners and siblings), (B) any entities controlled by, controlling or under common control with
the Member, (C) any trust for the direct or indirect benefit of the Member or the immediate family of the Member, (D) if the Member is a trust, the trustor or beneficiary of such trust or to the estate of a beneficiary of such trust, and (E) if the
Member is an entity, any direct or indirect partners, members or equity holders of the Member, any affiliate (as defined in Rule 405 promulgated under the Securities Act) of the Member or any related investment funds or vehicles controlled or
managed by such persons or entities or their respective affiliates;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Person</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">an individual, a partnership, a corporation, a company, a limited liability company, an association, a joint stock company, a trust, a joint venture, an unincorporated organization and a governmental entity or any department, agency
or political subdivision thereof;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Preference Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">has the meaning given to that term in Bye-law 4;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Principal Executive Officer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the person appointed by the Board to serve as the Principal Executive Officer of the Company for the time being in accordance with Bye-law 47(c);</TD></TR></TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
<DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Register of Directors</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">and Officers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the register of Directors and Officers referred to in these Bye-laws;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Register of Members</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the register of Members referred to in these Bye-laws;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Resident Representative</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">any Person appointed to act as resident representative and includes any deputy or assistant resident representative;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Secretary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Person appointed to perform any or all of the duties of secretary of the Company and includes any deputy or assistant secretary and any Person appointed by the Board to perform any of the duties of the Secretary;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">the Common Shares and the Preference Shares (if issued);</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Subsidiary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">in respect of any Person means another Person, of which a majority of the securities or ownership interests having by their terms ordinary voting power to elect a majority of the board of directors or other persons performing
similar functions is owned or controlled directly or indirectly by such first Person;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Treasury Share</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">a share of the Company that was or is treated as having been acquired and held by the Company and has been held continuously by the Company since it was so acquired and has not been cancelled; and</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Upstream Equity Holder</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">with respect to a Member, means its direct or indirect stockholders, partners, members or other equity holders.</TD></TR>
</TABLE></DIV> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In these Bye-laws, where not inconsistent with the context: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">words denoting the plural number include the singular number and vice versa; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">words denoting the masculine gender include the feminine and neuter genders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">words importing Persons include companies, associations or bodies of Persons whether corporate or not;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the words: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;may&#148; shall be construed as permissive; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;shall&#148; shall be construed as imperative; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a reference to statutory provision shall be deemed to include any amendment or re-enactment thereof;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the word &#147;corporation&#148; means a corporation whether or not a company within the meaning of the Act;
and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">unless otherwise provided herein, words or expressions defined in the Act shall bear the same meaning in these
Bye-laws. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In these Bye-laws expressions referring to writing or its cognates shall, unless the contrary intention
appears, include facsimile, printing, lithography, photography, electronic mail and other modes of representing words in visible form. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Headings used in these Bye-laws are for convenience only and are not to be used or relied upon in the
construction hereof. </P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SHARES </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Power to Issue Shares </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to these Bye-laws and to any resolution of the Members to the contrary, and without prejudice to any
special rights previously conferred on the holders of any existing shares or class of shares, the Board shall have the power to issue any unissued shares on such terms and conditions as it may determine. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the Act, any preference shares may be issued or converted into shares that (at a determinable date
or at the option of the Company or the holder) are liable to be redeemed on such terms and in such manner as may be determined by the Board (before the issue or conversion). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Power of the Company to Purchase its Shares </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company may purchase its own shares for cancellation or acquire them as Treasury Shares in accordance with
the Act on such terms as the Board shall think fit. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board may exercise all the powers of the Company to purchase or acquire all or any part of its own shares
in accordance with the Act. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Rights Attaching to Shares </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At the date these Bye-Laws are adopted, the share capital of the Company comprises a single class of common
shares, par value U.S.$0.0000001 (the &#147;<B>Common Shares</B>&#148;). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The holders of the Common Shares shall, subject to the provisions of these Bye-laws: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">be entitled to one vote per share; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">be entitled to such dividends as the Board may from time to time declare; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the event of a winding-up or dissolution of the Company, whether voluntary or involuntary or for the purpose
of a reorganization or otherwise or upon any distribution of capital, be entitled to the surplus assets of the Company; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">generally be entitled to enjoy all of the rights attaching to shares. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board is authorised to provide for the creation and issuance of preference shares
(the&nbsp;&#147;<B>Preference Shares</B>&#148;) in one or more series, and to establish from time to time the number of shares to be included in each such series, and to fix the terms, including designation, powers, preferences, rights,
qualifications, limitations and restrictions of the shares of each such series (and, for the avoidance of doubt, such matters and the issuance of such Preference Shares with prior ranking shall not be deemed to vary the rights attached to the Common
Shares or, subject to the terms of any other series of Preference Shares, to vary the rights attached to any other series of Preference Shares). The authority of the Board with respect to each series shall include, but not be limited to,
determination of the following: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the number of shares constituting that series and the distinctive designation of that series;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the dividend rate on the shares of that series, whether dividends shall be cumulative and, if so, from which
date or dates, and the relative rights of priority, if any, of the payment of dividends on shares of that series; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">whether that series shall have voting rights, in addition to the voting rights provided by law, and if so, the
terms of such voting rights; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">whether that series shall have conversion or exchange privileges (including, without limitation, conversion
into Common Shares), and, if so, the terms and conditions of such conversion or exchange, including provision for adjustment of the conversion or exchange rate in such events as the Board shall determine; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">whether or not the shares of that series shall be redeemable or repurchaseable, and, if so, the terms and
conditions of such redemption or repurchase, including the manner of selecting shares for redemption or repurchase if less than all shares are to be redeemed or repurchased, the date or dates upon or after which they shall be redeemable or
repurchaseable, and the amount per share payable in case of redemption or repurchase, which amount may vary under different conditions and at different redemption or repurchase dates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">whether that series shall have a sinking fund for the redemption or repurchase of shares of that series, and,
if so, the terms and amount of such sinking fund; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the right of the shares of that series to the benefit of conditions and restrictions upon the creation of
indebtedness of the Company or any Subsidiary, upon the issue of any additional shares (including additional shares of such series or any other series) and upon the payment of dividends or the making of other distributions on, and the purchase,
redemption or other acquisition by the Company or any Subsidiary of any issued shares of the Company; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the rights of the shares of that series in the event of voluntary or involuntary liquidation, dissolution or
winding up of the Company, and the relative rights of priority, if any, of payment in respect of shares of that series; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the rights of holders of that series to elect or appoint directors; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any other relative participating, optional or other special rights, qualifications, limitations or restrictions
of that series. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any Preference Shares of any series which have been redeemed (whether through the operation of a sinking fund
or otherwise) or which, if convertible or exchangeable, have been converted into or exchanged for shares of any other class or classes shall have the status of authorised and unissued Preference Shares of the same series and may be reissued as a
part of the series of which they were originally a part or may be reclassified and reissued as part of a new series of Preference Shares to be created by resolution or resolutions of the Board or as part of any other series of Preference Shares, all
subject to the conditions and the restrictions on issuance set forth in the resolution or resolutions adopted by the Board providing for the issue of any series of Preference Shares. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At the discretion of the Board, whether or not in connection with the issuance and sale of any shares or other
securities of the Company, the Company may issue securities, contracts, warrants or other instruments evidencing any shares, option rights, securities having conversion or option rights, or obligations on such terms, conditions and other provisions
as are fixed by the Board, including, without limiting the generality of this authority, conditions that preclude or limit any Person or Persons owning or offering to acquire a specified number or percentage of the issued Common Shares, other
shares, option rights, securities having conversion or option rights, or obligations of the Company or transferee of the Person or Persons from exercising, converting, transferring or receiving the shares, option rights, securities having conversion
or option rights, or obligations. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All the rights attaching to a Treasury Share shall be suspended and shall not be exercised by the Company while
it holds such Treasury Share and, except where required by the Act, all Treasury Shares shall be excluded from the calculation of any percentage or fraction of the share capital, or shares, of the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Lock-Up </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To the extent not prohibited by applicable law and except as set forth in Bye-laws 5(2) and 5(3), no Member
shall (i)&nbsp;lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or
indirectly, (a)&nbsp;any Common Shares that are outstanding immediately prior to the time at which the Company becomes subject to the reporting requirements of the Exchange Act (such time, the &#147;<B>Listing Time</B>&#148;), or (b)&nbsp;any
securities that are outstanding immediately prior to the Listing Time that are convertible into or exercisable or exchangeable (directly or indirectly) for Common Shares (including without limitation, Common Shares or other securities that may be
issued after the Listing Time upon exercise, vesting or settlement, as applicable, of any stock option, restricted stock unit, capped value appreciation right or other equity or equity-based award or interest (the securities described in this clause
(b), the &#147;<B>Other Securities</B>&#148;)), or (ii)&nbsp;enter into any swap, hedge or other arrangement that transfers to another, in whole or in part, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
any of the economic consequences of ownership of any Common Shares or Other Securities, whether any such transaction described in clause (i)&nbsp;or (ii)&nbsp;above is to be settled by delivery
of Common Shares or Other Securities, in cash, or otherwise, and whether any such transaction is made or executed by or on behalf of someone other than the Member (each, a &#147;<B>Sale Transaction</B>&#148;), for a period of one-hundred eighty
(180)&nbsp;days following the Listing Time (the &#147;<B>Lock-Up Period</B>&#148;), in each case, without the prior written consent from the Board. The Company may impose stop-transfer instructions with respect to the Common Shares and Other
Securities subject to the restrictions set forth in this Bye-law 5(1). </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The restrictions set forth in Bye-law 5(1) shall not apply to: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the sale of any Common Shares to an underwriter pursuant to an underwriting agreement to which the Company is a
party in connection with a Member&#146;s exercise of piggyback registration rights set forth in, and in accordance with the terms and conditions of, the Company&#146;s Third Amended and Rested Registration Rights Agreement, dated on or about the
date of these Bye-laws; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a transfer of any or all of Common Shares or Other Securities (I)&nbsp;by gift, will, intestate succession or
charitable contribution, (II) to any Permitted Transferee, (III) by operation of law or pursuant to a court order or an order of a regulatory agency, such as a qualified domestic relations order, divorce decree or separation agreement, (IV) to the
Company pursuant to the exercise, in each case on a &#147;cashless&#148; or &#147;net exercise&#148; basis, of any Other Securities (provided that any Common Shares received by a Member upon any such exercise will be subject to the terms of Bye-law
5(1)), (V)&nbsp;for purposes of satisfying any withholding taxes and/or estimated taxes due as a result of the exercise, vesting or settlement, as applicable, of any Other Securities, (VI) in connection with the Company&#146;s consummation of a
liquidation, merger, amalgamation, share exchange, reorganization, tender offer or other similar transaction that results in all of the Company&#146;s Members having the right to exchange their equity holdings in the Company for cash, securities or
other property, or (VII) by pledging, hypothecating or otherwise granting a security interest in Common Shares or Other Securities in a bona fide transaction to one or more unaffiliated lending institutions as&nbsp;collateral&nbsp;or security for
any margin loan and any transfer in the event of foreclosure upon such Common Shares or Other Securities as a result of a default on such margin loan (so long as any such pledge, hypothecation or grant of security interest shall be on terms
consistent with customary margin loans, and the applicable Member shall provide the Company with written notice prior to entering into such margin loan); provided, however, that in the case of any of the foregoing clauses (I), (II) or (III), the
transferee in such transfer shall agree in a writing delivered to the Company that the Common Shares or Other Securities so transferred will thereafter continue be subject to the terms of Bye-law 5(1); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the establishment or modification of a written plan meeting the requirements of Rule 10b5-1 of the Exchange Act
that does not provide for the sale or transfer of Common Shares during the Lock-up Period (provided that, to the extent a public announcement or filing under the Exchange Act is required regarding the establishment or modification of such plan, such
announcement or filing shall include a statement to the effect that no sales or transfers of Common Shares may be made under such plan during the Lock-up Period); or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a sale or other transfer by an Upstream Equity Holder of its direct or indirect common stock or membership,
partnership or other equity ownership interest in a Member (whether or not for consideration). </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Each Member agrees to
execute and deliver such other customary agreements as may be reasonably requested by the Company or the managing underwriter in an underwritten transaction that are consistent with Bye-law 5(1) or that are necessary to give further effect thereto.
If any Sale Transaction is made or attempted contrary to the provisions of Bye-Law 5(1) and Bye-law 5(2), such purported Sale Transaction shall be null and void <I>ab initio</I>, and the Company shall refuse to recognize any such purported
transferee of the applicable Common Shares or Other Securities as one of its equity holders or Members for any purpose. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding anything to the contrary set forth herein, the provisions of Bye-law 5(1) and Bye-law 5(2)
shall not apply to any Common Shares or Other Securities held by or on behalf of any shareholder of Montes Archimedes Acquisition Corp. (&#147;MAAC&#148;) (other than a shareholder of MAAC who is also a Member (or other holder of Common Shares or
Other Securities of the Company) that did not purchase its shares of MAAC directly from MAAC) prior to, or received in connection with, the closing of the transactions contemplated by that certain Business Combination Agreement, dated May&nbsp;1,
2021, by and among the Company, MAAC and Rhine Merger Sub, Inc. (including, for the avoidance of doubt, any shares issued in the private placement contemplated thereby or any shares held by Patient Square Capital LLC, including, in each case, Common
Shares or Other Securities received in exchange for, or converted for, securities received in such private placement or in connection with such Business Combination Agreement). </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Calls on Shares </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board may make such calls as it thinks fit upon the Members in respect of any monies (whether in respect of
nominal value or premium) unpaid on the shares allotted to or held by such Members (and not made payable at fixed times by the terms and conditions of issue) and, if a call is not paid on or before the day appointed for payment thereof, the Member
may at the discretion of the Board be liable to pay the Company interest on the amount of such call at such rate as the Board may determine, from the date when such call was payable up to the actual date of payment. The Board may differentiate
between the holders as to the amount of calls to be paid and the times of payment of such calls. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any amount which, by the terms of issue of a share, becomes payable upon issue or at any fixed date, whether on
account of the nominal value of the share or by way of premium, shall for the purposes of these Bye-laws be deemed to be an amount on which a call has been duly made and payable on the date on which, by the terms of issue, the same becomes payable,
and in case of non-payment all the relevant provisions of these Bye-laws as to payment of interest, costs and expenses, forfeiture or otherwise shall apply as if such amount had become payable by virtue of a duly made and notified call.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The joint holders of a share shall be jointly and severally liable to pay all calls and any interest, costs and
expenses in respect thereof. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company may accept from any Member the whole or a part of the amount remaining unpaid on any shares held by
such Member, although no part of that amount has been called up or become payable. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Forfeiture of Shares </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If any Member fails to pay, on the day appointed for payment thereof, any call in respect of any share allotted
to or held by such Member, the Board may, at any time thereafter during such time as the call remains unpaid, direct the Secretary to forward such Member a notice in writing in the form, or as near thereto as circumstances admit, of the following:
</P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notice of Liability to Forfeiture for Non-Payment of Call </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Roivant Sciences Ltd.</B> (the &#147;<B>Company</B>&#148;)<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">You have failed to pay the call of [amount of call] made on the [ ] day of [ ], 20[ ], in respect of the [number] share(s) [number in figures]
standing in your name in the Register of Members of the Company, on the [ ] day of [ ], 20[ ], the day appointed for payment of such call. You are hereby notified that unless you pay such call together with interest thereon at the rate of [ ] per
annum computed from the said [ ] day of [ ], 20[ ] at the registered office of the Company the share(s) will be liable to be forfeited. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Dated this [ ] day of [], 20[ ] </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">[Signature of Secretary] By Order of the Board </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the requirements of such notice are not complied with, any such share may at any time thereafter before the
payment of such call and the interest due in respect thereof be forfeited by a resolution of the Board to that effect, and such share shall thereupon become the property of the Company and may be disposed of as the Board shall determine. Without
limiting the generality of the foregoing, the disposal may take place by sale, repurchase, redemption or any other method of disposal permitted by and consistent with these Bye-laws and the Act. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A Member whose share or shares have been so forfeited shall, notwithstanding such forfeiture, be liable to pay
to the Company all calls owing on such share or shares at the time of the forfeiture, together with all interest due thereon and any costs and expenses incurred by the Company in connection therewith. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board may accept the surrender of any shares which it is in a position to forfeit on such terms and
conditions as may be agreed. Subject to those terms and conditions, a surrendered share shall be treated as if it had been forfeited. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Share Certificates </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the provisions of this Bye-law 8, every Member shall be entitled to a certificate under the common
seal (or a facsimile thereof) of the Company or bearing the signature (or a facsimile thereof) of a Director or Secretary or a Person expressly authorized to sign specifying the number and, where appropriate, the class of shares held by such Member
and whether the same are fully paid up and, if not, specifying the amount paid on such shares. The Board may by resolution determine, either generally or in a particular case, that any or all signatures on certificates may be printed thereon or
affixed by mechanical means. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company shall be under no obligation to complete and deliver a share certificate unless specifically called
upon to do so by the Person to whom the shares have been allotted. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If any share certificate shall be proved to the satisfaction of the Board to have been worn out, lost, mislaid,
or destroyed the Board may cause a new certificate to be issued and request an indemnity for the lost certificate if it sees fit. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding any provisions of these Bye-laws: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Board shall, subject always to the Act and any other applicable laws and regulations and the facilities and
requirements of any relevant system concerned, have power to implement any arrangements they may, in their absolute discretion, think fit in relation to the evidencing of title to and transfer of uncertificated shares and to the extent such
arrangements are so implemented, no provision of these Bye-laws shall apply or have effect to the extent that it is in any respect inconsistent with the holding or transfer of shares in uncertificated form; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">unless otherwise determined by the Board and as permitted by the Act and any other applicable laws and
regulations, no Person shall be entitled to receive a certificate in respect of any share for so long as the title to that share is evidenced otherwise than by a certificate and for so long as transfers of that share may be made otherwise than by a
written instrument. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For such time as any shares of the Company are traded on an Appointed Stock Exchange, nothing in these Bye-laws
shall prevent title to any shares of the Company from being evidenced and/or transferred without a written instrument in accordance with the rules or regulations applicable to shares listed on any such Appointed Stock Exchange, and the Board shall
have power to implement any arrangements which it may think fit for such evidencing and/or transfer. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Fractional Shares </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company may issue its shares in fractional denominations and deal with such fractions to the same extent as its whole shares and shares in fractional
denominations shall have in proportion to the respective fractions represented thereby all of the rights of whole shares including (but without limiting the generality of the foregoing) the right to vote, to receive dividends and distributions and
to participate in a winding-up. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION OF SHARES </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Register of Members </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board shall cause to be kept in one or more books a Register of Members and shall enter therein the
particulars required by the Act. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Register of Members shall be open to inspection without charge at the registered office of the Company on
every Business Day, subject to such reasonable restrictions as the Board may impose, so that not less than two hours in each Business Day be allowed for inspection. The Register of Members may, after notice has been given in accordance with the Act,
be closed for any time or times not exceeding in the whole thirty days in each year. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Registered Holder Absolute Owner </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company shall be entitled to treat the registered holder of any share as the absolute owner thereof and accordingly shall not be bound to recognize any
equitable claim or other claim to, or interest in, such share on the part of any other Person. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Transfer of Registered Shares </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the provisions of these Bye-laws and the Act, an instrument of transfer shall be in writing in such
form as the Board may accept. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Such instrument of transfer shall be signed by (or in the case of a party that is a corporation, on behalf of)
the transferor and transferee, provided that, in the case of a fully paid Share, the Board may accept the instrument signed by or on behalf of the transferor alone. The transferor shall be deemed to remain the holder of such share until the same has
been registered as having been transferred to the transferee in the Register of Members. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board may refuse to recognize any instrument of transfer unless it is accompanied by the certificate in
respect of the Shares to which it relates, to the extent that any such certificate was issued, and by such other evidence as the Board may reasonably require showing the right of the transferor to make the transfer. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the restrictions set out in these Bye-laws, the joint holders of any Share may transfer such Share
to one or more of such joint holders, and the surviving holder or holders of any Share previously held by them jointly with a deceased Member may transfer any such Share to the executors or administrators of such deceased Member.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board may in its absolute discretion and without assigning any reason therefor refuse to register the
transfer of a share which is not fully paid up. The Board shall refuse to register a transfer unless all applicable consents, authorizations and permissions of any governmental body or agency in Bermuda have been obtained. If the Board refuses to
register a transfer of any Share the Secretary shall, within ten Business Days after the date on which the transfer was lodged with the Company, send to the transferor and transferee notice of the refusal. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares may be transferred without a written instrument if transferred by an appointed agent or otherwise in
accordance with the Act. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding anything to the contrary in these Bye-laws, shares that are listed or admitted to trading on an
Appointed Stock Exchange may be transferred in accordance with the rules and regulations of such exchange. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Transmission of Registered Shares </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the case of the death of a Member, the survivor or survivors where the deceased Member was a joint holder,
and the legal personal representatives of the deceased Member where the deceased Member was a sole holder, shall be the only Persons recognised by the Company as having any title to the deceased Member&#146;s interest in the
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
shares. Nothing herein contained shall release the estate of a deceased joint holder from any liability in respect of any share which had been jointly held by such deceased Member with other
Persons. Subject to the Act, for the purpose of this Bye-law, legal personal representative means the executor or administrator of a deceased Member or such other Person as the Board may, in its absolute discretion, decide as being properly
authorised to deal with the shares of a deceased Member. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any Person becoming entitled to a Share in consequence of the death, bankruptcy or liquidation of any Member
may be registered as a Member upon such evidence as the Board may deem sufficient or may elect to nominate some Person to be registered as a transferee of such Share, and in such case the Person becoming entitled shall execute in favor of such
nominee an instrument of transfer in writing in the form, or as near thereto as circumstances admit, of the following: </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Transfer by a Person Becoming Entitled on Death/Bankruptcy/Liquidation of a Member <B>Roivant Sciences Ltd.</B> (the
&#147;<B>Company</B>&#148;) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">I/We, having become entitled in consequence of the [death/bankruptcy/liquidation] of [name and address of
deceased/bankrupt/liquidated Member] to [number] share(s) standing in the Register of Members of the Company in the name of the said [name of deceased/bankrupt/liquidated Member] instead of being registered myself/ourselves, elect to have [name of
transferee] (the &#147;<B>Transferee</B>&#148;) registered as a transferee of such share(s) and I/we do hereby accordingly transfer the said share(s) to the Transferee to hold the same unto the Transferee, his or her executors, administrators and
assigns, subject to the conditions on which the same were held at the time of the execution hereof; and the Transferee does hereby agree to take the said share(s) subject to the same conditions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">DATED this [date] </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Signed by:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">In the presence of:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> &nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> &nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">Transferor</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Witness</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" ALIGN="center">Signed by:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">In the presence of:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> &nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"> &nbsp;<P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">Transferee</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Witness</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On the presentation of the foregoing materials to the Board, accompanied by such evidence as the Board may
require to prove the title of the transferor, the transferee shall be registered as a Member. Notwithstanding the foregoing, the Board shall, in any case, have the same right to decline or suspend registration as it would have had in the case of a
transfer of the Share by that Member before such Member&#146;s death, bankruptcy, or liquidation, as the case may be. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Where two or more Persons are registered as joint holders of a Share or Shares, then in the event of the death
of any joint holder or holders the remaining joint holder or holders shall be absolutely entitled to such Share or Shares and the Company shall recognize no claim in respect of the estate of any joint holder except in the case of the last survivor
of such joint holders. </P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ALTERATION OF SHARE CAPITAL </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Power to Alter Capital </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company may if authorized by a resolution of the Members entitled to vote thereon increase, divide,
consolidate, subdivide, change the currency denomination of, diminish or otherwise alter or reduce its share capital in any manner permitted by the Act. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Where, on any alteration or reduction of share capital, fractions of Shares or some other difficulty would
arise, the Board may deal with or resolve the same in such manner as it thinks fit. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Variation of Rights Attaching to Shares </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If, at any time, the share capital is divided into different classes of shares, the rights attached to any class (unless otherwise provided by the terms of
issue of the shares of that class) may, whether or not the Company is being wound-up, be varied with the consent in writing of the holders of at least two-thirds of the issued shares of that class or with the sanction of a resolution passed by the
affirmative votes of a majority of the votes cast at a separate general meeting of the holders of the shares of the class at which meeting the necessary quorum shall be one or more Persons holding or representing by proxy at least a majority of the
issued shares of the class. The rights conferred upon the holders of the shares of any class or series issued with preferred or other rights shall not, unless otherwise expressly provided by the terms of issue of the shares of that class or series,
be deemed to be varied by the creation or issue of further shares ranking <I>pari passu</I> therewith. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DIVIDENDS AND CAPITALIZATION
</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Dividends </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to these Bye-laws and in accordance with the Act, the Board may declare a dividend to be paid to the
Members, and any such dividend shall be paid in accordance with Bye-law 18. Subject to these Bye-laws and in accordance with the Act, such dividend may be paid in cash or wholly or partly <I>in specie</I> in which case the Board may fix the value
for distribution <I>in specie</I> of any assets. No unpaid dividend shall bear interest as against the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board may fix any date as the record date for determining the Members entitled to receive any dividend.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company may pay dividends in proportion to the amount paid up on each share where a larger amount is paid
up on some shares than on others. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to these Bye-laws and in accordance with the Act, the Board may declare and make such other
distributions (in cash or in specie) to the Members as may be lawfully made out of the assets of the Company, and any such distribution shall be paid in accordance with Bye-law 18. No unpaid distribution shall bear interest as against the Company.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Power to Set Aside Profits </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board may, before declaring a dividend, set aside out of the surplus or profits of the Company, such amount as it thinks proper as a reserve to be used to
meet contingencies or for equalizing dividends or for any other purpose. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>18.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Method of Payment </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any dividend, interest, or other monies payable in cash in respect of the Shares may be paid by check, wire
transfer or draft sent through the post directed to the Member at such Member&#146;s address in the Register of Members, or to such Person and to such address as the Member may in writing direct. Every such check, wire or draft shall be made payable
to the order of the Person to whom it is sent or to such Persons as the Member may direct in writing, and payment of the check, wire or draft shall be a good discharge to the Company. Every such check, wire or draft shall be sent at the risk of the
Person entitled to the money represented thereby. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the case of joint holders of Shares, any dividend, interest or other monies payable in cash in respect of
Shares may be paid by check, wire transfer or draft sent through the post directed to the address of the holder first named in the Register of Members, or to such Person and to such address as the joint holders may in writing direct. If two or more
Persons are registered as joint holders of any Shares any one can give an effectual receipt for any dividend paid in respect of such Shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board may deduct from the dividends or distributions payable to any Member all monies due from such Member
to the Company on account of calls or otherwise </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any dividend and/or other monies payable in respect of a Share that has remained unclaimed for six years from
the date when it became due for payment shall, if the Board so resolves, be forfeited and cease to remain owing by the Company. The payment of any unclaimed dividend or other monies payable in respect of a Share may (but need not) be paid by the
Company into an account separate from the Company&#146;s own account. Such payment shall not constitute the Company a trustee in respect thereof. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company shall be entitled to cease sending dividend checks and warrants by post or otherwise to a Member if
those instruments have been returned undelivered to, or left uncashed by, that Member on at least two consecutive occasions or, following one such occasion, reasonable inquiries have failed to establish the Member&#146;s new address. The entitlement
conferred on the Company by this Bye-law 18 in respect of any Member shall cease if the Member claims a dividend or cashes a dividend check or warrant. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>19.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Capitalization </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board may capitalize any amount for the time being standing to the credit of any of the Company&#146;s
share premium or other reserve accounts or to the credit of the profit and loss account or otherwise available for distribution by applying such amount in paying up unissued Shares to be allotted as fully paid bonus shares pro rata to the Members.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board may capitalize any amount for the time being standing to the credit of a reserve account or amounts
otherwise available for dividend or distribution by applying such amounts in paying up in full, partly or nil paid Shares of those Members who would have been entitled to such amounts if they were distributed by way of dividend or distribution.
</P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEETINGS OF MEMBERS </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>20.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Annual General Meetings </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An annual general meeting shall be held in each year at such time and place as the Principal Executive Officer of the Company or chairperson of the Board or
any two Directors or any Director and the Secretary or the Board shall appoint. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>21.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Special General Meetings </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Principal Executive Officer of the Company, the chairperson of the Board, or the Board by the affirmative vote of the majority of the Board may convene a
special general meeting whenever in their judgment such a meeting is necessary. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>22.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Requisitioned General Meetings </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board shall, on the requisition of Members holding at the date of the deposit of the requisition not less than 10% of the paid-up share capital of the
Company as at the date of the deposit carries the right to vote at general meetings, forthwith proceed to convene a special general meeting and the provisions of the Act shall apply. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>23.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Notice </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At least fourteen days&#146; notice of an annual general meeting shall be given to each Member entitled to
attend and vote thereat, stating the date, place and time at which the meeting is to be held, whether any election of Directors will take place thereat, and as far as practicable, the other business to be conducted at the meeting.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At least ten days&#146; notice of a special general meeting shall be given to each Member entitled to attend
and vote thereat, stating the date, time, place and the general nature of the business to be considered at the meeting. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board may fix any date as the record date for determining the Members entitled to receive notice of and to
vote at any general meeting. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A general meeting shall, notwithstanding that it is called on shorter notice than that specified in these
Bye-laws, be deemed to have been properly called if it is so agreed by (i)&nbsp;all the Members entitled to attend and vote thereat in the case of an annual general meeting; and (ii)&nbsp;by a majority in number of the Members having the right to
attend and vote at the meeting, being a majority together holding not less than 95% in nominal value of the shares giving a right to attend and vote thereat in the case of a special general meeting. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The accidental omission to give notice of a general meeting to, or the non-receipt of a notice of a general
meeting by, any Person entitled to receive notice shall not invalidate the proceedings at that meeting. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>24.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Giving Notice and Access </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A notice may be given by the Company to a Member: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by delivering it to such Member in person, in which case the notice shall be deemed to have been served upon
such delivery; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by sending it by post to such Member&#146;s address in the Register of Members, in which case the notice shall
be deemed to have been served seven days after the date on which it is deposited, with postage prepaid, in the mail; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by sending it by courier to such Member&#146;s address in the Register of Members, in which case the notice
shall be deemed to have been served two days after the date on which it is deposited, with courier fees paid, with the courier service; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by transmitting it by electronic means (including facsimile and electronic mail, but not telephone) in
accordance with such directions as may be given by such Member to the Company for such purpose, in which case the notice shall be deemed to have been served at the time that it would in the ordinary course be transmitted; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by delivering it in accordance with the provisions of the Act pertaining to delivery of electronic records by
publication on a website, in which case the notice shall be deemed to have been served at the time when the requirements of the Act in that regard have been met. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any notice required to be given to a Member shall, with respect to any shares held jointly by two or more
Persons, be given to whichever of such Persons is named first in the Register of Members and notice so given shall be sufficient notice to all the holders of such shares. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In proving service under paragraphs 24(1)(b), (1)(c)&nbsp;and (1)(d), it shall be sufficient to prove that the
notice was properly addressed and prepaid, if posted or sent by courier, and the time when it was posted, deposited with the courier, or transmitted by electronic means. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>25.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Postponement or Cancellation of General Meeting </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Principal Executive Officer of the Company, the chairperson of the Board or the Secretary may postpone or cancel any general meeting called in accordance
with these Bye-laws (other than a meeting requisitioned under these Bye-laws) provided that notice of postponement or cancellation is given to the Members before the time for such meeting. Fresh notice of the date, time and place for any postponed
meeting shall be given to each Member in accordance with these Bye-laws. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>26.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Notice of Nominations and Member Business </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Annual General Meetings </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Nominations of Persons for election to the Board or the proposal of other business to be transacted by the
Members may be made at an annual general meeting only </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
(A) pursuant to the Company&#146;s notice of meeting (or any supplement thereto), (B)&nbsp;by or at the direction of the Board or (C)&nbsp;subject to any applicable law (including as provided for
in Bye-law 26(1)(e), in the case of proposals of any business other than in respect of Director nominations), by Members of record at the time of giving of notice as provided for in this Bye-law 26(1) and who comply with the notice procedures set
forth in this Bye-law 26(1); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For nominations or other business to be properly brought before an annual general meeting by a Member pursuant
to clause (C)&nbsp;of Bye-law 26(1)(a), the Member must have given timely notice thereof in writing to the Secretary and any such proposed business must constitute a proper matter for Member action. To be timely, a Member&#146;s notice shall be
delivered to or mailed and received by the Secretary at the registered office of the Company not less than ninety (90)&nbsp;days nor more than one-hundred twenty (120)&nbsp;days prior to the first anniversary of the preceding year&#146;s annual
general meeting; provided, that in the event that the date of the annual general meeting is called for a date that is not less than thirty (30)&nbsp;days before or after such anniversary then to be timely such notice must be received at the
registered office of the Company not later than ten (10)&nbsp;days following the earlier of the date on which notice of the annual general meeting was posted to Members or the date on which public disclosure of the date of the annual general meeting
was made. In no event shall the public announcement of an adjournment or postponement of an annual general meeting commence a new time period (or extend any time period) for the giving of a Member&#146;s notice as described above. For purposes of
Bye-laws 26(1)(b) and 26(2), &#147;public announcement&#148; shall mean disclosure in a press release reported by the Dow Jones News Service, the Associated Press, PR Newswire, Businesswire, Bloomberg or any comparable news service in the United
States or in a document publicly filed by the Company with the Securities and Exchange Commission pursuant to Section&nbsp;13, 14 or 15(d) of the Exchange Act; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A Member&#146;s notice to the Secretary shall set forth (A)&nbsp;as to each Person whom the Member proposes to
nominate for election or reelection as a director all information relating to such Person that is required to be disclosed in solicitations of proxies for election of directors, or is otherwise required, in each case pursuant to Section&nbsp;14(a)
of the Exchange Act (including such Person&#146;s written consent to being named in the proxy statement as a nominee and to serving as a director if elected), (B)&nbsp;as to any other business that the Member proposes to bring before the general
meeting, a brief description of the business desired to be brought before the general meeting, the text of the proposal or business, the reasons for conducting such business at the general meeting and any material interest in such business of such
Member and the beneficial owner, if any, on whose behalf the proposal is made, and (C)&nbsp;as to the Member giving the notice and the beneficial owner, if any, on whose behalf the proposal is made: </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the name and address of such Member (as they appear in the Register of Members) and any such beneficial owner;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the class or series and number of shares of the Company which are held of record or are beneficially owned by
such Member and by any such beneficial owner; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a description of any agreement, arrangement or understanding between or among such Member and any such
beneficial owner, any of their respective affiliates or associates, and any other Person or Persons (including their names) in connection with the proposal of such nomination or other business; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a description of any agreement, arrangement or understanding (including, regardless of the form of settlement,
any derivative, long or short positions, profit interests, forwards, futures, swaps, options, warrants, convertible securities, share appreciation or similar rights, hedging transactions and borrowed or loaned shares) that has been entered into by
or on behalf of, or any other agreement, arrangement or understanding that has been made, the effect or intent of which is to create or mitigate loss to, manage risk or benefit of share price changes for, or increase or decrease the voting power of,
such Member or any such beneficial owner or any such nominee with respect to the Company&#146;s securities (a &#147;<B>Derivative Instrument</B>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to the extent not disclosed pursuant to clause (iv)&nbsp;above, the principal amount of any indebtedness of the
Company or any of its Subsidiaries beneficially owned by such Member or by any such beneficial owner, together with the title of the instrument under which such indebtedness was issued and a description of any Derivative Instrument entered into by
or on behalf of such Member or such beneficial owner relating to the value or payment of any indebtedness of the Company or any such Subsidiary; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a representation that the Member is a holder of record of shares of the Company entitled to vote at such
general meeting and intends to appear in person or by proxy at the general meeting to bring such nomination or other business before the general meeting; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a representation as to whether such Member or any such beneficial owner intends or is part of a group that
intends to (i)&nbsp;deliver a proxy statement and/or form of proxy to holders of at least the percentage of the voting power of the Company&#146;s outstanding shares required to approve or adopt the proposal or to elect each such nominee and/or
(ii)&nbsp;otherwise to solicit proxies from Members in support of such proposal or nomination. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If requested by the Company, the information required under clauses (ii), (iii), (iv)&nbsp;and (v)&nbsp;of
Bye-law 26(1)(c) shall be supplemented by such Member and any such beneficial owner not later than ten (10)&nbsp;days after the record date for notice of the general meeting to disclose such information as of such record date; </P></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Nothing in this Bye-law (or the foregoing provisions) shall apply to any proposal made pursuant to Rule 14a-8
promulgated under the Exchange Act, as amended. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Special General Meetings </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Only such business shall be conducted at a special general meeting as shall have been brought before the
general meeting in accordance with the Company&#146;s notice of meeting pursuant to Bye-laws 23 or 24; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Nominations of Persons for election to the Board at a special general meeting may be made (i)&nbsp;by or at the
direction of the Board or (ii)&nbsp;provided that the Board has determined that Members may nominate Persons for election to the Board at such general meeting, by any Member of the Company who is a Member of record at the time of giving of notice
provided for in this Bye-law 26(2)(b), who shall be entitled to vote at the general meeting and who complies with the notice procedures set forth in this Bye-law 26; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For nominations to be properly brought before a special general meeting by a Member pursuant to Bye-law
26(2)(b)(ii), the Member must have given timely notice thereof in writing to the Secretary. To be timely, a Member&#146;s notice and nominations of persons for election as Directors shall specify whether those persons nominated are nominated as
replacements of existing Directors and, if so, which Directors they are proposed to replace and shall be delivered to or mailed and received at the registered office of the Company not later than seven (7)&nbsp;days following the earlier of the date
on which notice of the special general meeting was posted to Members or the date on which public disclosure of the date of the special general meeting was made; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A Member&#146;s notice to the Secretary, including any notice of requisition pursuant to Bye-law 21, shall
comply with the notice requirements of Bye-law 26(1)(c) and (d). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">General </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At the request of the Board, any Person nominated by the Board for election as a director shall furnish to the
Secretary the information that is required to be set forth in a Member&#146;s notice of nomination pursuant to Bye-law 26(1)(c). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No Person shall be eligible to be nominated by a Member to serve as a director of the Company unless nominated
in accordance with the procedures set forth in this Bye-law 26. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The chairperson of the general meeting shall, if the facts warrant, determine and declare to the general
meeting that a nomination was not made in accordance with the procedures prescribed by these Bye-laws or that business was not properly brought before the general meeting, and if he or she should so determine and declare, the defective nomination
shall be disregarded or such business shall not be transacted, as the case may be. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding the foregoing provisions of this Bye-law 26, unless otherwise required by the Act, if the
Member (or a qualified representative of the Member) does not appear at the annual or special general meeting to present a nomination or other proposed business, such nomination shall be disregarded or such proposed business shall not be transacted,
as the case may be, notwithstanding that proxies in respect of such vote may have been received by the Company. For purposes of this Bye-law 26(3), to be considered a qualified representative of the Member, a Person must be a duly authorized
officer, manager or partner of such Member or must be authorized by a writing executed by such Member or an electronic transmission delivered by such Member to act for such Member as proxy at the general meeting and such Person must produce such
writing or electronic transmission, or a reliable reproduction of the writing or electronic transmission, at the general meeting. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Without limiting the foregoing provisions of this Bye-law 26, a Member shall also comply with all applicable
requirements of the Exchange Act, and the rules and regulations thereunder with respect to the matters set forth in this Bye-law&nbsp;26; provided, that any references in these Bye-laws to the Exchange Act, or the rules and regulations promulgated
thereunder are not intended to and shall not limit any requirements applicable to nominations or proposals as to any other business to be considered pursuant to this Bye-law, and compliance with Bye-law&nbsp;26(1) or 26(2) shall be the exclusive
means for a Member to make nominations or submit other business (other than as provided in Bye-law 26(1)(e)). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>27.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Electronic Participation and Security at General Meetings </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Members may participate in any general meeting by such telephonic, electronic or other communication facilities
or means as permit all Persons participating in the meeting to communicate with each other simultaneously and instantaneously, and participation in such a meeting shall constitute presence in person at such meeting </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board may, and at any general meeting, the chairperson of such meeting may make any arrangement and impose
any requirement or restriction it or he or she considers appropriate to ensure the security of a general meeting including, without limitation, requirements for evidence of identity to be produced by those attending the meeting, the searching of
their personal property and the restriction of items that may be taken into the meeting place. The Board and, at any general meeting, the chairperson of such meeting are entitled to refuse entry to a Person who refuses to comply with any such
arrangements, requirements or restrictions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>28.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Quorum at General Meetings </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At any general meeting two or more Persons present in person and representing in person or by proxy in excess
of 50% of the total voting rights of all issued and outstanding shares of the Company shall form a quorum for the transaction of business. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If within half an hour from the time appointed for the meeting a quorum is not present, then, in the case of a
meeting convened on a requisition, the meeting shall be deemed cancelled and, in any other case, the meeting shall stand adjourned to the same day one week later, at the same time and place or to such other day, time or place as the Secretary may
determine. Unless the meeting is adjourned to a specific date, time and place announced at the meeting being adjourned, fresh notice of the resumption of the meeting shall be given to each Member entitled to attend and vote thereat in accordance
with these Bye-laws. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>29.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Chairperson to Preside at General Meetings </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The chairperson of the Board, or any other director designated by the chairperson or by the Board in his or her absence, shall act as chairperson of the
meeting at all general meetings. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>30.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Voting on Resolutions </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to any rights and restrictions for the time being attached to any class or classes or series of shares,
every Member shall have one vote for each share carrying the right to vote on the matter in question of which he or she is the holder. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the Act and these Bye-laws, any question proposed for the consideration of the Members at any
general meeting shall be decided by the affirmative votes of a majority of the votes cast by the Members in accordance with these Bye-laws and in the case of an equality of votes the resolution shall fail. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No Member shall be entitled to vote at a general meeting unless such Member has paid all the calls on all
shares held by such Member. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At any general meeting a resolution put to the vote of the meeting shall, in the first instance, be voted upon
by a show of hands or by a count of votes received in the form of electronic records and, subject to these Bye-laws and any rights or restrictions for the time being lawfully attached to any class of shares, every Member present in person and every
Person holding a valid proxy at such meeting shall be entitled to one vote for each share of which such Person is the holder or for which such Person holds a proxy and shall cast such votes by raising his or her hand or by communicating his or her
vote in the form of an electronic record. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event that a Member participates in a general meeting by telephone, electronic or other communications
facilities or means, the chairperson of the meeting shall direct the manner in which such Member may cast his or her vote on a show of hands or by communicating his or her vote in the form of an electronic record. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At any general meeting if an amendment is proposed to any resolution under consideration and the chairperson of
the meeting rules on whether or not the proposed amendment is out of order, the proceedings on the substantive resolution shall not be invalidated by any error in such ruling </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At any general meeting a declaration by the chairperson of the meeting that a question proposed for
consideration has been carried, or carried unanimously, or by a particular majority, or lost, and an entry to that effect in a book containing the minutes of the proceedings of the Company shall, subject to these Bye-laws, be conclusive evidence of
that fact. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>31.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Power to Demand a Vote on a Poll </B></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding anything in these Bye-laws to the contrary, a poll may be demanded by any of the following
persons: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The chairperson of such meeting; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At least three Members present in person or represented by proxy; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any Member or Members present in person or represented by proxy and holding between them not less than
one-tenth of the total voting rights of all the Members having the right to vote at such meeting; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any Member or Members present in person or represented by proxy holding shares in the Company conferring the
right to vote at such meeting, being shares on which an aggregate sum has been paid up equal to not less than one-tenth of the total amount paid up on all such shares conferring such right. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Where a poll is demanded, subject to any rights or restrictions for the time being lawfully attached to any
class of shares, every Person present at a meeting of the Members shall have one vote for each Share of which such Person is the holder or for which such Person holds a proxy and such votes shall be counted by ballot as described herein, or in the
case of a general meeting at which one or more Members are present by telephone, electronic or other communication facilities or means, in such manner as the chairperson of the meeting may direct and the result of such poll shall be deemed to be the
resolution of the meeting at which the poll was demanded and shall replace any previous resolution upon the same matter which has been the subject of a show of hands or in the form of an electronic record. A Person entitled to more than one vote
need not use all his votes or cast all the votes he or she uses in the same way. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A poll demanded for the purpose of electing a chairperson of the meeting or on a question of adjournment shall
be taken forthwith. A poll demanded on any other question shall be taken at such time and in such manner during such meeting as the chairperson (or acting chairperson) of the meeting may direct. Any business other than that upon which a poll has
been demanded may be conducted pending the taking of the poll. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Where a vote is taken by poll, each Person physically present and entitled to vote shall be furnished with a
ballot paper on which such Person shall record his vote in such manner as shall be determined at the meeting having regard to the nature of the question on which the vote is taken, and each ballot paper shall be signed or initialed or otherwise
marked so as to identify the voter and the registered holder in the case of a proxy. Each Person present by telephone, electronic or other communication facilities or means shall cast his vote in such manner as the chairperson of the meeting shall
direct. At the conclusion of the poll, the ballot papers and votes cast in accordance with such directions shall be examined and counted by one or more inspectors of votes or a committee appointed by the chairperson of the meeting for the purpose
and the result of the poll shall be declared by the chairperson of the meeting. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>32.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Voting by Joint Holders of Shares </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the case of joint holders, the vote of the senior who tenders a vote (whether in person or by proxy) shall be accepted to the exclusion of the votes of the
other joint holders, and for this purpose seniority shall be determined by the order in which the names stand in the Register of Members. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>33.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Instrument of Proxy </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A member may appoint a proxy by (a)&nbsp;an instrument appointing the proxy which shall be such form as the
Board or the chairperson of the meeting shall accept or (b)&nbsp;such telephonic, electronic or other means as may be approved by the Board from time to time. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The appointment of a proxy must be received by the Company at the registered office or at such other place or
in such manner as is specified in the notice convening the meeting or in any instrument of a proxy sent out by the Company in relation to the meeting at which the Person named in the appointment proposes to vote, and an appointment of a proxy which
is not received in the manner so prescribed shall be invalid. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A Member who is the holder of two or more Shares may appoint more than one proxy to represent him or her and
vote on his or her behalf in respect of different shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The decision of the chairperson of any general meeting as to the validity of any appointment of a proxy shall
be final. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>34.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Representation of Corporate Member </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A corporation which is a Member may, by written instrument, authorize such natural Person or Persons as it
thinks fit to act as its representative at any meeting and any Person so authorized shall be entitled to exercise the same powers on behalf of the corporation which such Person represents as that corporation could exercise if it were an individual
Member, and that Member shall be deemed to be present in Person at any such meeting attended by its authorized representative or representatives. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding the foregoing, the chairperson of the meeting may accept such assurances as he or she thinks
fit as to the right of any Person to attend and vote at general meetings on behalf of a corporation which is a Member. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>35.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Adjournment of General Meeting </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The chairperson of a general meeting may adjourn the meeting, (a)&nbsp;with the affirmative vote of a majority
of votes cast by the Members present at any general meeting at which a quorum is present or at his initiative, and (c)&nbsp;shall adjourn the meeting, if so directed by the meeting. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In addition, the chairperson of a general meeting may adjourn the meeting to another time and place without
such consent or direction if it appears to him or her that: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">it is likely to be impracticable to hold or continue that meeting because of the number of Members wishing to
attend who are not present; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the unruly conduct of Persons attending the meeting prevents, or is likely to prevent, the orderly continuation
of the business of the meeting; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">an adjournment is otherwise necessary so that the business of the meeting may be properly conducted.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless the meeting is adjourned to a specific date, place and time announced at the meeting being adjourned,
fresh notice of the date, place and time for the resumption of the adjourned meeting shall be given to each Member entitled to attend and vote thereat in accordance with these Bye-laws. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>36.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Written Resolutions </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to these Bye-laws, anything which may be done by resolution of the Company in general meeting or by
resolution of a meeting of any class of the Members may be done without a meeting by written resolution in accordance with this Bye-law 36. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notice of a written resolution shall be given, and a copy of the resolution shall be circulated to all Members
who would be entitled to attend a meeting and vote thereon. The accidental omission to give notice to, or the non-receipt of a notice by, any Member does not invalidate the passing of a resolution. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A written resolution is passed when it is signed by (or in the case of a Member that is a corporation, on
behalf of) the Members who at the date that the notice is given represent such majority of votes as would be required if the resolution was voted on at a meeting of Members at which all Members entitled to attend and vote thereat were present and
voting. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Prompt notice of the taking of a corporate action by less than unanimous written resolution shall be delivered
to all Members who, if the action had been taken at a meeting, would have been entitled to notice of such meeting if the record date for notice of such meeting had been the date that written resolutions signed by a sufficient number of Members to
take the action were delivered to the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A resolution in writing may be signed in any number of counterparts. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A resolution in writing made in accordance with this Bye-law 36 is as valid as if it had been passed by the
Company in general meeting or by a meeting of the relevant class of Members, as the case may be (provided that (i)&nbsp;any such resolution shall be valid only if the signature of the last Member to sign is affixed outside the United States (unless
the Board dispenses with this requirement), and (ii)&nbsp;the Board may declare such resolution to be invalid if the Board determines that the use of a resolution in writing would result in a non-de minimis adverse tax, regulatory or legal
consequence to the Company, any Subsidiary of the Company, or any direct or indirect holder of shares or its Affiliates), and any reference in any Bye-law to a meeting at which a resolution is passed or to Members voting in favor of a resolution
shall be construed accordingly. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A resolution in writing made in accordance with this Bye-law 36 shall constitute minutes for the purposes of
the Act. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Bye-law 36 shall not apply to a resolution passed to remove a Director or an Auditor from office before
the expiration of his term of office; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For the purposes of this Bye-law 36, the effective date of the resolution is the date when the resolution is
signed by (or in the case of a Member that is a corporation, on behalf of) the last Member whose signature results in the necessary voting majority being achieved and any reference in any Bye-law to the date of passing of a resolution is, in
relation to a resolution made in accordance with this Bye-law 36, a reference to such date. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>37.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Directors Attendance at General Meetings </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Directors shall be entitled to receive notice of, attend and be heard at any general meeting. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DIRECTORS AND OFFICERS </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>38.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Election of Directors </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Only Persons who are proposed or nominated in accordance with Bye-law 26 shall be eligible for election as
Directors. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Where Persons are validly proposed for re-election or election as a Director, the persons receiving the most
votes (up to the number of Directors to be elected) shall be elected as Directors. Cumulative voting shall not be permitted. It shall also not be a prerequisite to the election of directors to receive either an absolute majority of the issued and
outstanding voting shares or a majority of votes cast. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At any general meeting the Members may authorise the Board to fill any vacancy in his or her number left
unfilled at a general meeting. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All acts done in good faith by the Board, any Director, a member of a committee appointed by the Board, any
person to whom the Board may have delegated any of its powers shall, or any person acting as a Director shall, notwithstanding that it be afterwards discovered that there was some defect in the appointment of any Director or person acting as
aforesaid, or that he or she was, or any of them were, disqualified, be as valid as if every such person had been duly appointed and was qualified to be a Director or act in the relevant capacity. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>39.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Number of Directors </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Board shall consist of such number of Directors being not less than five (5)&nbsp;Directors and not more than such maximum number of
Directors as the Board may from time to time determine, being initially fifteen (15)&nbsp;Directors. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>40.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Classes of Directors </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Directors shall be divided into three classes designated Class I, Class II and Class III. Each class of Directors shall consist, as nearly
as possible, of one third of the total number of Directors constituting the entire Board. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>41.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Term of Office of Directors </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Class I Directors shall initially hold office for a one year term, the Class II Directors shall initially hold office for a two year term
and the Class III Directors shall initially hold office for a three year term. At each succeeding annual general meeting, successors to the class of Directors whose term expires at that annual general meeting shall be elected for a three year term.
If the number of Directors is changed, any increase or decrease </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
shall be apportioned among the classes so as to maintain the number of Directors in each class as nearly equal as possible, and any Director of any class elected to fill a vacancy shall hold
office for a term that shall coincide with the remaining term of the other Directors of that class, but in no case shall a decrease in the number of Directors shorten the term of any Director then in office. A Director shall hold office until the
annual general meeting for the year in which his term expires, subject to his office being vacated pursuant to Bye-law 44. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>42.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Alternate Directors </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The election or appointment of a person or persons to act as a Director in the alternative to any one or more Directors shall not be permitted.
</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>43.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Removal of Directors </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to any provision to the contrary in these Bye-laws, the Members entitled to vote for the election of
Directors may, at any special general meeting convened and held in accordance with these Bye-laws, by the affirmative vote of at least 66 and 2/3% of the issued and outstanding voting shares entitled to vote for the election of directors to remove a
Director, only with cause, provided that the notice of any such meeting convened for the purpose of removing a Director shall contain a statement of the intention so to do and be served on such Director not less than fourteen (14)&nbsp;days before
the meeting and at such meeting the Director shall be entitled to be heard on the motion for such Director&#146;s removal. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If a Director is removed from the Board under this Bye-law, then the Members may fill the vacancy at the
meeting at which such Director is removed. In the absence of such election or appointment, the Board may fill the vacancy. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For the purposes of this Bye-law, &#147;cause&#148; shall mean (i)&nbsp;a conviction for a criminal offence
involving dishonesty or (ii)&nbsp;engaging in conduct which brings the Director or the Company into disrepute and which results in material financial detriment to the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>44.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Vacancy in the Office of Director </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The office of Director shall be vacated immediately if the Director: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is removed from office pursuant to Bye-law 43; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is prohibited from being a Director by law; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is or becomes bankrupt, or makes any arrangement or composition with his creditors generally;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is or becomes of unsound mind or dies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">resigns his or her office by notice to the Company (unless such other later date is agreed by the Board); or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">is not reelected to office under Bye-law 41 past the expiry of his or her term. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Members in general meeting or the Board shall have the power to appoint any Person as a Director to fill a
vacancy on the Board occurring as a result of the death, disability, disqualification or resignation of any Director or as a result of an increase in the size of the Board. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>45.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Remuneration of Directors </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The remuneration (if any) of the Directors shall be determined by the Board or a committee thereof and shall be deemed to accrue from day to day. The Directors
may also be paid all travel, hotel and other expenses properly incurred by them in attending and returning from the Board meetings, meetings of any committee appointed by the Board, general meetings, or in connection with the business of the Company
or their duties as Directors generally. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>46.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Directors to Manage Business </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The business of the Company shall be managed and conducted by the Board. In managing the business of the Company, the Board may exercise all such powers of the
Company as are not, by the Act or by these Bye-laws, required to be exercised by the Company in general meeting. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>47.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Powers of the Board of Directors </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board may, among other things, and without limiting general authority provided in Bye-law 46, or otherwise hereunder: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">appoint, suspend, or remove any manager, secretary, clerk, agent or employee of the Company and may fix their
remuneration and determine their duties; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">exercise all the powers of the Company to borrow money and to mortgage or charge or otherwise grant a security
interest in its undertaking, property and uncalled capital, or any part thereof, and may issue debentures, debenture stock and other securities whether outright or as security for any debt, liability or obligation of the Company or any third party;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">appoint one or more Persons to the office of managing director or Principal Executive Officer of the Company,
who shall, subject to the control of the Board, supervise and administer all of the general business and affairs of the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">appoint a person to act as manager of the Company&#146;s day-to-day business and may entrust to and confer upon
such manager such powers and duties as it deems appropriate for the transaction or conduct of such business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by power of attorney, appoint any company, firm, Person or body of Persons, whether nominated directly or
indirectly by the Board, to be an attorney of the Company for such purposes and with such powers, authorities and discretions (not exceeding those vested in or exercisable by the Board) and for such period and subject to such conditions as it may
think fit and any such power of attorney may contain such provisions for the protection and convenience of Persons dealing with any such attorney as the Board may think fit and may also authorize any such attorney to sub-delegate all or any of the
powers, authorities and discretions so vested in the attorney; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">procure that the Company pays all expenses incurred in promoting and incorporating the Company and listing the
shares of the Company on any exchange in the United States or any other jurisdiction; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">delegate any of its powers (including the power to sub-delegate) to a committee of one or more Persons
appointed by the Board which may consist partly or entirely of non-Directors, provided that every such committee shall conform to such directions as the Board shall impose on them and provided further that the meetings and proceedings of any such
committee shall be governed by the provisions of these Bye-laws regulating the meetings and proceedings of the Board, so far as the same are applicable and are not superseded by directions imposed by the Board; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">delegate any of its powers (including the power to sub-delegate) to any Person on such terms and in such manner
as the Board may see fit; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">present any petition and make any application in connection with the liquidation or reorganization of the
Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in connection with the issue of any share, pay such commission and brokerage as may be permitted by law; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(k)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">authorize any company, firm, Person or body of Persons to act on behalf of the Company for any specific purpose
and in connection therewith to execute any deed, agreement, document or instrument on behalf of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>48.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Register of Directors and Officers </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board shall cause to be kept in one or more books at the registered office of the Company a Register of Directors and Officers and shall enter therein the
particulars required by the Act. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>49.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Appointment of Officers </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board may appoint such Officers (who may or may not be Directors) as the Board may determine for such terms as the Board deems fit. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>50.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Appointment of Secretary </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Secretary shall be appointed by the Board from time to time for such term as the Board deems fit. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>51.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Duties of Officers </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Officers shall have such powers and perform such duties in the management, business and affairs of the Company as may be delegated to them by the Board
from time to time. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>52.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Remuneration of Officers </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Officers shall receive such remuneration as the Board may determine. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>53.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Conflicts of Interest </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any Director, or any Director&#146;s firm, partner or any company with whom any Director is associated, may act
in any capacity for, be employed by or render services to the Company on such terms, including with respect to remuneration, as may be agreed between the parties. Nothing herein contained shall authorize a Director or a Director&#146;s firm, partner
or company to act as Auditor to the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A Director who is directly or indirectly interested in a contract or proposed contract with the Company (an
&#147;<B>Interested Director</B>&#148;) shall declare the nature of such interest as required by the Act. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to Bye-law 53(4), an Interested Director who has complied with the requirements of the foregoing
Bye-law may: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">vote in respect of such contract or proposed contract; and/or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">be counted in the quorum for the meeting at which the contract or proposed contract is to be voted on,
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">and no such contract or proposed contract shall be void or voidable by reason only that the Interested Director voted on
it or was counted in the quorum of the relevant meeting and the Interested Director shall not be liable to account to the Company for any profit realized thereby. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The chairperson of the relevant Board meeting may determine in his or her sole discretion that any Director who
has made a declaration under Bye-law 53(2) is disqualified from voting. The chairperson of a Board meeting may require a Director to leave the meeting to enable the Board to discuss and/or vote on a matter in which the chairperson considers the
Director to be interested. If a majority in number of the Directors in attendance at a Board meeting considers the chairperson of the meeting to be interested in a particular matter, they may require the chairperson to leave the meeting to enable
the Board to discuss and/or vote on such matter. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>54.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Corporate Opportunities </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To the fullest extent permitted by applicable law,(x) any Director who is not an officer or employee of the
Company or any subsidiary thereof and (y)&nbsp;his or her respective Affiliates of each person in clause (x)&nbsp;(the persons and entities in clauses (x)&nbsp;and (y)&nbsp;as aforesaid, each a &#147;<B>Covered Manager Person</B>&#148;), may, and
shall have no duty not to, (i)&nbsp;carry on and conduct, whether directly or indirectly, including (without limitation) as a partner in any partnership, as a joint venturer in any joint venture, or a director, officer, employee or shareholder of
any company, or as a participant in any syndicate, pool, trust or association, any business of any kind, nature or description, whether or not such business is competitive with or in the same or similar lines of business as the Company, (ii)&nbsp;do
business with any client, customer, vendor or other person that has a commercial relationship with the Company or any of its Affiliates, and (iii)&nbsp;have an interest, acquire or make, direct or advise on any investments in any kind of property in
which the Company may make investments, in each case of clauses (i), (ii)&nbsp;and (iii), whether existing as of the date of these Bye-laws are adopted or thereafter coming into existence. To the fullest extent permitted by law, the Company hereby
renounces any interest or expectancy of the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Company to participate in any business of the Covered Manager Persons, and waives any claim against a Covered Manager Person and shall indemnify a Covered Manager Person against any claim that
such Covered Manager Person is liable to the Company or its Members for breach of any fiduciary duty solely by reason of such person&#146;s or entity&#146;s participation in any such business. No Covered Manager Person nor any of their Affiliates
shall be obligated to account to the Company or to the Members for any profits or income earned or derived from such other activities, businesses, or ventures. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If a Covered Manager Person acquires knowledge of a potential transaction or matter which may constitute a
corporate opportunity for both (x)&nbsp;the Covered Manager Person (other than with respect to the Company) and (y)&nbsp;the Company, the Covered Manager Person shall not, to the fullest extent permitted by applicable law, have any duty to inform or
offer or communicate information regarding such corporate opportunity to the Company. To the fullest extent permitted by law, the Company hereby renounces any interest or expectancy of the Company in such corporate opportunity and waives any claim
against each Covered Manager Person and shall indemnify a Covered Manager Person against any claim that such Covered Manager Person is liable to the Company or its Members for breach of any fiduciary duty solely by reason of the fact that such
Covered Manager Person (i)&nbsp;pursues or acquires any corporate opportunity for the account of a corporation other than the Company, (ii)&nbsp;directs, recommends, sells, assigns, or otherwise transfers such corporate opportunity to another person
or (iii)&nbsp;does not communicate information regarding such corporate opportunity to the Company, <I>provided</I>, however, in each case, that any corporate opportunity which becomes known to a Covered Manager Person in his or her capacity as a
Director or Officer of the Company shall belong to the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Any person or entity purchasing or otherwise acquiring any interest in any Common Shares of the Company shall
be deemed to have notice of and to have consented to the provisions of this Bye-Law 54. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>55.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Indemnification and Exculpation of Directors and Officers </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Directors, Resident Representative, Secretary and other Officers (such term to include any Person appointed
to any committee by the Board) acting in relation to any of the affairs of the Company or any Subsidiary thereof and the liquidator or trustees (if any) acting in relation to any of the affairs of the Company or any Subsidiary thereof and every one
of them (whether for the time being or formerly), and their heirs, executors and administrators (each of which an &#147;<B>indemnified party</B>&#148;), shall be indemnified and secured harmless out of the assets of the Company from and against all
actions, costs, charges, losses, damages and expenses which they or any of them, their heirs, executors or administrators, shall or may incur or sustain by or by reason of any act done, concurred in or omitted in or about the execution of their
duty, or supposed duty, or in their respective offices or trusts, and no indemnified party shall be answerable for the acts, receipts, neglects or defaults of the others of them or for joining in any receipts for the sake of conformity, or for any
bankers or other Persons with whom any monies or effects belonging to the Company shall or may be lodged or deposited for safe custody, or for insufficiency or deficiency of any security upon which any monies of or belonging to the Company shall be
placed out on or invested, or for any other loss, misfortune or damage which may happen in the execution of their respective offices or trusts, or in relation thereto, provided that this indemnity shall not extend to any matter in respect of any
fraud or dishonesty in relation to the Company which may attach to any of the indemnified </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
parties or to any matter in respect of which such indemnified party did not act in good faith and in a manner such Person reasonably believed to be in or not opposed to the best interests of the
Company or, with respect to any criminal matter, had reasonable cause to believe such Person&#146;s conduct was unlawful. Each Member agrees to waive any claim or right of action such Member might have, whether individually or by or in the right of
the Company, against any Director or Officer on account of any action taken by such Director or Officer, or the failure of such Director or Officer to take any action in the performance of his or her duties with or for the Company or any Subsidiary
thereof, provided that such waiver shall not extend to any matter in respect of any fraud or dishonesty in relation to the Company which may attach to such Director or Officer or to any matter in respect of which such indemnified party did not act
in good faith and in a manner such Person reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal matter, had reasonable cause to believe such Person&#146;s conduct was unlawful.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company shall purchase and maintain insurance for the benefit of any Director or Officer against any
liability incurred by him under the Act in his or her capacity as a Director or Officer or indemnifying such Director or Officer in respect of any loss arising or liability attaching to him by virtue of any rule of law in respect of any negligence,
default, breach of duty or breach of trust of which the Director or Officer may be guilty in relation to the Company or any Subsidiary thereof. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company may advance monies to a Director or Officer for the costs, charges and expenses incurred by the
Director or Officer in defending any civil or criminal proceedings against him or her, on condition that the Director or Officer shall repay the advance if any allegation of fraud or dishonesty in relation to the Company is proved against him or
her. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No amendment or repeal of any provision of this Bye-law 55 shall alter, to the detriment of any Person, the
right of such Person to the indemnification or advancement of expenses related to a claim based on an act or failure to act which took place prior to such amendments. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEETINGS OF THE BOARD OF DIRECTORS </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>56.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Board Meetings </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board may meet for the transaction of business, adjourn and otherwise regulate its meetings as it sees fit. A resolution put to the vote at a Board meeting
shall be carried by the affirmative votes of a majority of the votes cast by the Directors, and in the case of an equality of votes the resolution shall fail. The chairperson of the Board (if any) does not have a casting vote. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>57.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Notice of Board Meetings </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A Director may, and the Secretary on the requisition of a Director shall, at any time summon a Board meeting. Notice of a Board meeting shall be deemed to be
duly given to a Director if it is given to such Director verbally (including in person or by telephone) or otherwise communicated or sent to such Director by post, electronic means or other mode of representing words in a visible form at such
Director&#146;s last known address or in accordance with any other instructions given by such Director to the Company for this purpose. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>58.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Electronic Participation in Meetings </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Directors may participate in any meeting by such telephonic, electronic or other communication facilities or means as permit all Persons participating in the
meeting to communicate with each other simultaneously and instantaneously, and participation in such a meeting shall constitute presence in person at such meeting. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>59.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Quorum at Board Meetings </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The quorum necessary for the transaction of business at a Board meeting shall be a majority of the members of the Board in office at the relevant time. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>60.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Chairperson to Preside </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise agreed by a majority of the Directors attending a Board meeting, the chairperson of the Board shall act as chairperson of the meeting at all
Board meetings at which such Person is present. In his or her absence a chairperson shall be appointed or elected by the Directors present at the meeting. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>61.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Written Resolutions </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to these Bye-laws, anything which may be done by resolution of the Board at a meeting duly called and
constituted may be done without a meeting by unanimous written resolution in accordance with this Bye-law 61. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A resolution signed by all the Directors, which may be in counterparts, shall be as valid as if it had been
passed at a Board meeting duly called and constituted, such resolution to be effective on the date on which the resolution is signed by the last Director, <I>provided, that</I> (i)&nbsp;any such resolution shall be valid only if the signature of the
last Director to sign is affixed outside the United States (unless the Board dispenses with this requirement), and (ii)&nbsp;the Board may declare such resolution to be invalid if the Board determines that the use of a resolution in writing would
result in a non-de minimis adverse tax, regulatory or legal consequence to the Company, any Subsidiary of the Company, or any direct or indirect holder of shares or its Affiliates. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A resolution in writing made in accordance with this Bye-law 61 shall constitute minutes for the purposes of
the Act. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>62.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Validity of Prior Acts of the Board </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No regulation or alteration to these Bye-laws made by the Company in general meeting shall invalidate any prior act of the Board which would have been valid if
that regulation or alteration had not been made. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CORPORATE RECORDS </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>63.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Minutes </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board shall cause minutes to be duly entered in books provided for the purpose: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">of all elections and appointments of Officers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">of the names of the Directors present at each Board meeting and of any committee appointed by the Board; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">of all resolutions and proceedings of general meetings of the Members, Board meetings, meetings of managers and
meetings of committees appointed by the Board. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>64.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Corporate Records </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Minutes prepared in accordance with the Act and these Bye-laws shall be kept by the Secretary at the registered
office of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company shall maintain all books and records in accordance with Bermuda law. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>65.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Form and Use of Seal </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company may adopt a seal in such form as the Board may determine. The Board may adopt one or more duplicate
seals for use in or outside Bermuda. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A seal may, but need not, be affixed to any deed, instrument or document, and if the seal is to be affixed
thereto, it shall be attested by the signature of (i)&nbsp;any Director, or (ii)&nbsp;any Officer, or (iii)&nbsp;the Secretary, or (iv)&nbsp;any Person authorized by the Board for that purpose. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A Resident Representative may, but need not, affix the seal of the Company to certify the authenticity of any
copies of documents. </P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ACCOUNTS </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>66.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Records of Account </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board shall cause to be kept proper records of account with respect to all transactions of the Company and
in particular with respect to: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all amounts of money received and expended by the Company and the matters in respect of which the receipt and
expenditure relates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all sales and purchases of goods by the Company; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">all assets and liabilities of the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Such records of account shall be kept at the registered office of the Company or, subject to the Act, at such
other place as the Board thinks fit and shall be available for inspection by the Directors during normal business hours. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Such records of account shall be retained for a minimum period of seven years from the date on which they are
prepared. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>67.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Financial Year End </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The financial year end of the Company may be determined by resolution of the Board and failing such resolution shall be 31st&nbsp;March in each year. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AUDITS </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>68.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Annual Audit </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to any rights to waive laying of accounts or appointment of an Auditor pursuant to the Act and pursuant to this Bye-law 68, the accounts of the Company
shall be audited at least once in every year. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>69.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Appointment of Auditor </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Subject to the Act, the Board shall appoint an auditor to the Company to hold office for each fiscal year. Such
appointment shall be submitted to the Members for their ratification and approval at the annual general meeting or at a subsequent special general meeting. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Auditor may not be a Member and no Director, Officer or employee of the Company shall, during his or her
continuance in office, be eligible to act as an Auditor of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>70.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Remuneration of Auditor </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The remuneration of an Auditor shall be fixed by the Board. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>71.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Duties of Auditor </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The financial statements provided for by these Bye-laws shall be audited by the Auditor in accordance with
generally accepted auditing standards. The Auditor shall make a written report thereon in accordance with generally accepted auditing standards. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The generally accepted auditing standards referred to in this Bye-law 71 may be those of a country or
jurisdiction other than Bermuda or such other generally accepted auditing standards as may be provided for in the Act. If so, the financial statements and the report of the Auditor shall identify the generally accepted auditing standards used.
</P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>72.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Access to Records </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Auditor shall at all reasonable times have access to all books kept by the Company and to all accounts and vouchers relating thereto, and the Auditor may
call on the Directors or Officers for any information in their possession relating to the books or affairs of the Company. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>73.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Financial Statements and the Auditor&#146;s Report </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The financial statements and/or the Auditor&#146;s report as required by the Act shall: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">be laid before the Members at the annual general meeting; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">be received, accepted, adopted, approved or otherwise acknowledged by the Members by written resolution passed
in accordance with these Bye-laws. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>74.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Vacancy in the Office of Auditor </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board may fill any casual vacancy in the office of the Auditor. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BUSINESS COMBINATIONS </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>75.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Business Combinations </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(i) Any Business Combination with any Interested Member (as defined below) within a period of three
(3)&nbsp;years following the time of the transaction in which the Person becomes an Interested Member must be approved by the Board and authorised at an annual or special general meeting, by the affirmative vote of at least 66 and 2/3% of the issued
and outstanding voting shares of the Company that are not owned by the Interested Member unless: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">prior to the time that the Person became an Interested Member, the Board approved either the Business
Combination or the transaction which resulted in the Person becoming an Interested Member; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">upon consummation of the transaction which resulted in the Person becoming an Interested Member, the Interested
Member owned at least 85% of the number of issued and outstanding voting shares of the Company at the time the transaction commenced, excluding for the purposes of determining the number of shares issued and outstanding those shares owned
(i)&nbsp;by Persons who are Directors and also officers and (ii)&nbsp;employee share plans in which employee participants do not have the right to determine whether shares held subject to the plan will be tendered in a tender or exchange offer.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The restrictions contained in this Bye-law 75(1) shall not apply if: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a Member becomes an Interested Member inadvertently and (i)&nbsp;as soon as practicable divests itself of
ownership of sufficient shares so that the Member ceases to be an Interested Member; and (ii)&nbsp;would not, at any time within the three-year period immediately prior to a Business Combination between the Company and such Member, have been an
Interested Member but for the inadvertent acquisition of ownership; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Business Combination is proposed prior to the consummation or abandonment of, and subsequent to the earlier
of the public announcement or the notice required hereunder of, a proposed transaction which (i)&nbsp;constitutes one of the transactions described in the following sentence; (ii)&nbsp;is with or by a Person who either was not an Interested Member
during the previous three years or who became an Interested Member with the approval of the Board; and (iii)&nbsp;is approved or not opposed by a majority of the members of the Board then in office who were Directors prior to any Person becoming an
Interested Member during the previous three years or were recommended for election or elected to succeed such Directors by resolution of the Board approved by a majority of such Directors. The proposed transactions referred to in the preceding
sentence are limited to: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a merger, amalgamation or consolidation of the Company (except an amalgamation or merger in respect of which,
pursuant to the Act, no vote of the Members of the Company is required); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a sale, lease, exchange, mortgage, pledge, transfer or other disposition (in one transaction or a series of
transactions), whether as part of a dissolution or otherwise, of assets of the Company or of any entity directly or indirectly wholly-owned or majority-owned by the Company (other than to the Company or any entity directly or indirectly wholly-owned
by the Company) having an aggregate market value equal to 50% or more of either the aggregate market value of all of the assets of the Company determined on a consolidated basis or the aggregate market value of all the issued and outstanding shares
of the Company; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a proposed tender or exchange offer for 50% or more of the issued and outstanding voting shares of the Company.
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The Company shall give not less than twenty (20)&nbsp;days notice to all Interested Members prior to the consummation of
any of the transactions described in subparagraphs (a)&nbsp;or (b)&nbsp;of the second sentence of this paragraph (ii). </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For the purpose of this Bye-law 75 only, the term: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;associate,&#148; when used to indicate a relationship with any Person, means: (i)&nbsp;any company,
partnership, unincorporated association or other entity of which such Person is a director, officer or partner or is, directly or indirectly, the owner of 20% or more of any class of voting shares; (ii)&nbsp;any trust or other estate in which such
Person has at least a 20% beneficial interest or as to which such Person serves as trustee or in a similar fiduciary capacity; and (iii)&nbsp;any relative or spouse of such Person, or any relative of such spouse, who has the same residence as such
Person; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Business Combination</B>,&#148; when used in reference to the Company and any Interested Member of the
Company, means: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any merger, amalgamation or consolidation of the Company or any entity directly or indirectly wholly-owned or
majority-owned by the Company, wherever incorporated, with (A)&nbsp;the Interested Member or any of its Affiliates, or (B)&nbsp;with any other company, partnership, unincorporated association or other entity if the merger, amalgamation or
consolidation is caused by the Interested Member; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any sale, lease, exchange, mortgage, pledge, transfer or other disposition (in one transaction or a series of
transactions), except proportionately as a Member of the Company, to or with the Interested Member, whether as part of a dissolution or otherwise, of assets of the Company or of any entity directly or indirectly wholly-owned or majority-owned by the
Company which assets have an aggregate market value equal to 10% or more of either the aggregate market value of all the assets of the Company determined on a consolidated basis or the aggregate market value of all the issued and outstanding shares
of the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any transaction which results in the issuance or transfer by the Company or by any entity directly or
indirectly wholly-owned or majority-owned by the Company of any shares of the Company, or any share of such entity, to the Interested Member, except: (A)&nbsp;pursuant to the exercise, exchange or conversion of securities exercisable for,
exchangeable for or convertible into shares of the Company, or shares of any such entity, which securities were issued and outstanding prior to the time that the Interested Member became such; (B)&nbsp;pursuant to a dividend or distribution paid or
made, or the exercise, exchange or conversion of securities exercisable for, exchangeable for or convertible into shares of the Company, or shares of any such entity, which security is distributed, pro rata to all holders of a class or series of
shares subsequent to the time the Interested Member became such; (C)&nbsp;pursuant to an exchange offer by the Company to purchase shares made on the same terms to all holders of such shares; or (D)&nbsp;any issuance or transfer of shares by the
Company; <I>provided however</I>, that in no case under items (B)-(D)&nbsp;of this subparagraph shall there be an increase in the Interested Member&#146;s proportionate share of any class or series of shares; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any transaction involving the Company or any entity directly or indirectly wholly-owned or majority-owned by
the Company which has the effect, directly or indirectly, of increasing the proportionate share of any class or series of shares, or securities convertible into any class or series of shares of the Company, or shares of any such entity, or
securities convertible into such shares, which is owned by the Interested Member, except as a result of immaterial changes due to fractional share adjustments or as a result of any repurchase or redemption of any shares not caused, directly or
indirectly, by the Interested Member; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">e.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any receipt by the Interested Member of the benefit, directly or indirectly (except proportionately as a Member
of the Company), of any loans, advances, guarantees, pledges or other financial benefits (other than those expressly permitted in subparagraphs (a)-(d)&nbsp;of this paragraph) provided by or through the Company or any entity directly or indirectly
wholly-owned or majority-owned by the Company; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;control,&#148; including the terms &#147;controlling,&#148; &#147;controlled by&#148; and &#147;under
common control with,&#148; means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting shares, by contract or otherwise. A Person who
is the owner of 20% or more of the issued and outstanding voting shares of any company, partnership, unincorporated association or other entity shall be presumed to have control of such entity, in the absence of proof by a preponderance of the
evidence to the contrary; <I>provided</I> that notwithstanding the foregoing, such presumption of control shall not apply where such Person holds voting shares, in good faith and not for the purpose of circumventing this provision, as an agent,
bank, broker, nominee, custodian or trustee for one or more owners who do not individually or as a group have control of such entity; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Interested Member</B>&#148; means any Person (other than the Company and any entity directly or
indirectly wholly-owned or majority-owned by the Company) that (i)&nbsp;is the owner of 15% or more of the issued and outstanding voting shares of the Company, (ii)&nbsp;is an Affiliate or associate of the Company and was the owner of 15% or more of
the issued and outstanding voting shares of the Company at any time within the three year period immediately prior to the date on which it is sought to be determined whether such Person is an Interested Member or (iii)&nbsp;is an Affiliate or
associate of any Person listed in (i)&nbsp;or (ii)&nbsp;above; <I>provided</I>, <I>however</I>, that the term &#147;Interested Member&#148; shall not include any Person whose ownership of shares in excess of the 15% limitation set forth herein is
the result of action taken solely by the Company unless such Person referred to in this proviso acquires additional voting shares of the Company otherwise than as a result of further corporate action not caused, directly or indirectly, by such
Person. For the purpose of determining whether a Person is an Interested Member, the voting shares of the Company deemed to be issued and outstanding shall include voting shares deemed to be owned by the Person through application of paragraph
(viii)&nbsp;below, but shall not include any other unissued shares which may be issuable pursuant to any agreement, arrangement or understanding, or upon exercise of conversion rights, warrants or options, or otherwise; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;Person&#148; means any individual, company, partnership, unincorporated association or other entity;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;voting shares&#148; means, with respect to any company, shares of any class or series entitled to vote
generally in the election of Directors,&nbsp;provided that, when used in reference to a vote to approve a merger or amalgamation of the Company which the Act requires to be approved by the Members, such term includes any shares entitled to vote on
such matter pursuant to the Act, whether or not they are otherwise entitled to vote and, with respect to any entity that is not a company, any equity interest entitled to vote generally in the election of the governing body of such entity;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;owner,&#148; including the terms &#147;own&#148; and &#147;owned,&#148; when used with respect to any
shares, means a Person that individually or with or through any of its Affiliates or associates: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">beneficially owns such shares, directly or indirectly; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">has (A)&nbsp;the right to acquire such shares (whether such right is exercisable immediately or only after the
passage of time) pursuant to any agreement, arrangement or understanding, or upon the exercise of conversion rights, exchange rights, warrants or options, or otherwise; <I>provided</I>, <I>however</I>, that a Person shall not be deemed the owner of
shares tendered pursuant to a tender or exchange offer made by such Person or any of such Person&#146;s Affiliates or associates until such tendered shares are accepted for purchase or exchange; or (B)&nbsp;the right to vote such shares pursuant to
any agreement, arrangement or understanding; <I>provided</I>, <I>however</I>, that a Person shall not be deemed the owner of any shares because of such Person&#146;s right to vote such shares if the agreement, arrangement or understanding to vote
such shares arises solely from a revocable proxy or consent given in response to a proxy or consent solicitation made to 10 or more Persons; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">has any agreement, arrangement or understanding for the purpose of acquiring, holding, voting (except voting
pursuant to a revocable proxy or consent as described in item (B)&nbsp;of subparagraph (b)&nbsp;of this paragraph), or disposing of such shares with any other Person that Beneficially Owns, or whose Affiliates or associates Beneficially Own,
directly or indirectly, such shares. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In respect of any Business Combination to which the restrictions contained in Bye-law 74(1) do not apply but
which the Act requires to be approved by the Members, the necessary general meeting quorum and Members&#146; approval shall be as set out in Bye-laws 28 and 30 respectively. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board shall ensure that the bye-laws or other constitutional documents of each entity wholly-owned or
majority-owned by the Company shall contain any provisions necessary to ensure that the intent of Bye-law 74(1), as it relates to the actions of such entities, is achieved. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>VOLUNTARY WINDING-UP AND DISSOLUTION </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>76.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Winding-Up </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Company shall be wound up the liquidator may, with the sanction of a resolution of the Members, divide amongst the Members in specie or in kind the
whole or any part of the assets of the Company (whether they shall consist of property of the same kind or not) and may, for such purpose, set such value as he or she deems fair upon any property to be divided as aforesaid and shall, in accordance
with the terms of these Bye-laws determine how such division shall be carried out as between the Members or different classes of Members. The liquidator may, with the like sanction, vest the whole or any part of such assets in the trustees upon such
trusts for the benefit of the Members as the liquidator shall think fit, but so that no Member shall be compelled to accept any shares or other securities or assets whereon there is any liability. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CHANGES TO CONSTITUTION </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>77.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Changes to Bye-laws </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No Bye-law may be rescinded, altered or amended and no new Bye-law may be made save in accordance with the Act and until the same has been approved by a
resolution of the Board and by a resolution of the Members holding at least 66 and 2/3% of the votes cast by the Members in accordance with these Bye-laws. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>78.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Changes to the Memorandum of Association </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No alteration or amendment to the Memorandum may be made save in accordance with the Act and until same has been approved by a resolution of the Board and by a
resolution of the Members holding at least 66 and 2/3% of the votes cast by the Members in accordance with these Bye-laws. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>79.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Discontinuance </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to these Bye-laws, the Board may exercise all the powers of the Company to discontinue the Company to a jurisdiction outside Bermuda pursuant to the
Act. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>80.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Amalgamation or Merger </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any resolution proposed for consideration at any general meeting to approve the amalgamation or merger of the Company with any other company, wherever
incorporated, shall (other than in respect of any amalgamation or merger constituting a Business Combination to which the restrictions in Bye-law 74 shall apply) require the approval of the affirmative votes of at least 66 and 2/3% of the votes cast
by the Members at such meeting and the quorum for such meeting shall be that required in Bye-law 28 and a poll may be demanded in respect of such resolution in accordance with the provisions of Bye-law 31. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>d230641dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXECUTION VERSION </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AMENDMENT NO. 2
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">to </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">SPONSOR SUPPORT AGREEMENT
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Amendment No.&nbsp;2 to the Sponsor Support Agreement (this &#147;<U>Amendment</U>&#148;) is made as of September&nbsp;30, 2021, by
and among Roivant Sciences Ltd., a Bermuda exempted limited company (the &#147;<U>Company</U>&#148;), Montes Archimedes Acquisition Corp., a Delaware corporation (&#147;<U>MAAC</U>&#148;), Patient Square Capital LLC, a Delaware limited liability
company (the &#147;<U>MAAC Sponsor</U>&#148;), and each of James C. Momtazee, George Barrett, Maria C. Walker and Steve Oesterle (collectively, the &#147;<U>Insiders</U>&#148; and, together with the MAAC Sponsor, the
&#147;<U>Shareholders</U>&#148;). Capitalized terms used, but not otherwise defined herein, shall have the meaning given to them in the Sponsor Support Agreement (as defined below) or the Business Combination Agreement (as defined below), as the
context so requires. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, (a)&nbsp;on May&nbsp;1, 2021 the Company, MAAC, the MAAC Sponsor and, solely for purposes of certain
provisions therein, the Insiders entered into that certain Sponsor Support Agreement and on June&nbsp;9, 2021 such parties entered into that certain Amendment No.&nbsp;1 to the Sponsor Support Agreement (such Sponsor Support Agreement, as amended by
Amendment No.&nbsp;1 thereto and as further amended, amended and restated, supplemented or otherwise modified from time to time in accordance with its terms, the &#147;<U>Sponsor Support Agreement</U>&#148;), and (b)&nbsp;on May&nbsp;1, 2021, MAAC,
the Company and Rhine Merger Sub, Inc., a Delaware corporation and a direct wholly owned Subsidiary of the Company, entered into that certain Business Combination Agreement (as amended, amended and restated, supplemented or otherwise modified from
time to time in accordance with its terms, including, for the avoidance of doubt, as amended by Amendment No.&nbsp;1 to the Business Combination Agreement, the &#147;<U>Business Combination Agreement</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, pursuant to Section&nbsp;16 of the Sponsor Support Agreement, the Sponsor Support Agreement may be amended if, and only if, such
amendment is in writing and signed by the Company, MAAC and the Shareholders; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company, MAAC and each Shareholder desires
to amend the Sponsor Support Agreement as set forth herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration for the mutual promises made herein and
other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company, MAAC and each Shareholder hereby agree to amend the Sponsor Support Agreement as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Amendments to the Sponsor Support Agreement</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Section 2(a) of the Sponsor Support Agreement is hereby amended and restated in its entirety and replaced with the
following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subject to, and conditioned upon the occurrence of and effective immediately after the Effective Time (as defined in the
BCA), (i)&nbsp;the number of Company Post-Closing Common Shares issued to the MAAC Sponsor, any Affiliate of the MAAC Sponsor, each MAAC Independent Director (as defined in the BCA) or any MAAC Independent Director Transferee (as defined in the BCA)
upon the conversion of MAAC Class&nbsp;B Shares held by him, her or it immediately prior to the Effective Time (rounded up to the nearest whole share) set forth in the table below under the heading &#147;20%
<FONT STYLE="white-space:nowrap">Earn-Out</FONT> Shares&#148; shall be subject to the provisions set forth below in this<U>&nbsp;Section</U><U></U><U>&nbsp;2</U> (such Company Post-Closing Common Shares, the &#147;<U>20% Earn</U><U><FONT
STYLE="white-space:nowrap">-Out</FONT> Shares</U>&#148;), (ii) the number of Company Post-Closing Common Shares issued to the MAAC Sponsor, any Affiliate of the MAAC Sponsor, each MAAC Independent Director or any MAAC Independent Director Transferee
upon the conversion of MAAC Class&nbsp;B Shares held by him, her or it </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
immediately prior to the Effective Time (rounded up to the nearest whole share) set forth in the table below under the heading &#147;10% <FONT STYLE="white-space:nowrap">Earn-Out</FONT>
Shares&#148; shall be subject to the provisions set forth below in this<U>&nbsp;Section</U><U></U><U>&nbsp;2</U> (such Company Post-Closing Common Shares, the &#147;<U>10% Earn</U><U><FONT STYLE="white-space:nowrap">-Out</FONT> Shares</U>&#148; and,
together with the 20% <FONT STYLE="white-space:nowrap">Earn-Out</FONT> Shares, the &#147;<U><FONT STYLE="white-space:nowrap">Earn-Out</FONT> Shares</U>&#148;) and (iii)&nbsp;the remaining number of Company Post-Closing Common Shares issued to the
MAAC Sponsor, any Affiliate of the MAAC Sponsor, each MAAC Independent Director or any MAAC Independent Director Transferee upon the conversion of MAAC Class&nbsp;B Shares held by him, her or it immediately prior to the Effective Time (rounded down
to the nearest whole share) set forth in the table below under the heading &#147;Retained Shares&#148; shall not be subject to the provisions set forth below in this<U>&nbsp;Section</U><U></U><U>&nbsp;2</U> (such Company Post-Closing Common Shares,
the &#147;<U>Retained Shares</U>&#148;). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>20%<BR><FONT STYLE="white-space:nowrap">Earn-Out&nbsp;Shares</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>10%<BR><FONT STYLE="white-space:nowrap">Earn-Out&nbsp;Shares</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Retained<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>The MAAC Sponsor and any Affiliate of the MAAC Sponsor</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,033,592</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,016,796</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,575,579</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Each MAAC Independent Director or any MAAC Independent Director Transferee</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Section 2(b) of the Sponsor Support Agreement is hereby amended and restated in its
entirety and replaced with the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) Subject to, and conditioned upon the occurrence of and effective immediately after the Effective Time, the <FONT
STYLE="white-space:nowrap">Earn-Out</FONT> Shares shall be unvested and subject to the restrictions and forfeiture provisions set forth in this <U>Section</U><U></U><U>&nbsp;2</U>. The <FONT STYLE="white-space:nowrap">Earn-Out</FONT> Shares shall
vest and become free of the provisions set forth in this <U>Section</U><U></U><U>&nbsp;2</U> at such time as the Stock Price (as defined below) of Company Post-Closing Common Shares equals or exceeds (x)&nbsp;with respect to the 20% <FONT
STYLE="white-space:nowrap">Earn-Out</FONT> Shares, $15.00 per share (the &#147;<U>20% Trigger Price</U>&#148;), and (y)&nbsp;with respect to the 10% <FONT STYLE="white-space:nowrap">Earn-Out</FONT> Shares, $20.00 per share (the &#147;<U>10% Trigger
Price</U>&#148; and, together with the 20% Trigger Price, the &#147;<U>Trigger Price</U>&#148;), in each case, for any 20 Trading Days within any 30 Trading Day period commencing on the earlier of (i)&nbsp;the date on which the registration
statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> required to be filed by the Company in connection with the PIPE Financing (as defined in the Business Combination Agreement) is declared effective by the U.S. Securities and Exchange
Commission or (ii)&nbsp;November&nbsp;15, 2021, and ending no later than the fifth (5th) anniversary of the Closing Date (the &#147;<U><FONT STYLE="white-space:nowrap">Earn-Out</FONT> End Date</U>&#148;); <U>provided</U>, <U>however</U>, that
(i)&nbsp;if the <FONT STYLE="white-space:nowrap">Earn-Out</FONT> End Date occurs on a day that is not a Trading Day, then the <FONT STYLE="white-space:nowrap">Earn-Out</FONT> End Date shall be deemed to occur on the next following Trading Day, and
(ii)&nbsp;if the Company or any of its Affiliates enters into a definitive agreement with respect to a Sale (as defined below) on or prior to the <FONT STYLE="white-space:nowrap">Earn-Out</FONT> End Date, then the
<FONT STYLE="white-space:nowrap">Earn-Out</FONT> End Date shall be automatically extended and shall be deemed to occur on the earlier of (A)&nbsp;the day after such Sale is consummated and (B)&nbsp;the termination of such definitive agreement with
respect to such Sale in accordance with its terms. Any <FONT STYLE="white-space:nowrap">Earn-Out</FONT> Shares that have not vested in accordance with this <U>Section</U><U></U><U>&nbsp;2(b)</U> or <U>Section</U><U></U><U>&nbsp;2(c</U>) on or before
the <FONT STYLE="white-space:nowrap">Earn-Out</FONT> End Date will be immediately forfeited at 11:59&nbsp;p.m., New York, New York time on the <FONT STYLE="white-space:nowrap">Earn-Out</FONT> End Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Effect of Amendments and Modifications</U>. Except as expressly amended hereby, the Sponsor Support Agreement shall remain unaltered and
in full force and effect and the respective terms, conditions or covenants thereof are hereby in all respects confirmed. Whenever the Sponsor Support Agreement is referred to in any agreement, document or other instrument, such reference will be to
the Sponsor Support as amended by this Amendment. For the avoidance of doubt, each reference in the Sponsor Support Agreement, as amended hereby, to &#147;the date hereof&#148;, the &#147;date of this Agreement&#148; and derivations thereof and
other similar phrases shall continue to refer to May&nbsp;1, 2021. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Miscellaneous</U>. Sections 8.5, 8.7, 8.10, 8.11, 8.15 and 8.16 of the Business
Combination Agreement are incorporated herein by reference, <I>mutatis mutandis</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[The remainder of this page intentionally left
blank.] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned have caused this Amendment to be signed as of the date
first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ROIVANT SCIENCES LTD.</B></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Marianne Romeo</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Marianne Romeo</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Head, Global Transactions&nbsp;&amp; Risk Management</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Amendment No.&nbsp;2 to the Sponsor Support Agreement] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned have caused this Amendment to be signed as of the date
first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>MONTES ARCHIMEDES ACQUISITION CORP.</B></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Maria C. Walker</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Maria C. Walker</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Financial Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Amendment No.&nbsp;2 to the Sponsor Support Agreement] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned have caused this Amendment to be signed as of the date
first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>PATIENT SQUARE CAPITAL LLC</B></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Maria C. Walker</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Maria C. Walker</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Financial Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Amendment No.&nbsp;2 to the Sponsor Support Agreement] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned have caused this Amendment to be signed as of the date
first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>INSIDERS</B></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ George Barrett</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">George Barrett</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Address:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Amendment No.&nbsp;2 to the Sponsor Support Agreement] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned have caused this Amendment to be signed as of the date
first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>INSIDERS</B></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ James C. Momtazee</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">James C. Momtazee</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Address:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Amendment No.&nbsp;2 to the Sponsor Support Agreement] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned have caused this Amendment to be signed as of the date
first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>INSIDERS</B></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Maria C. Walker</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Maria C. Walker</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Address:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Amendment No.&nbsp;2 to the Sponsor Support Agreement] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned have caused this Amendment to be signed as of the date
first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>INSIDERS</B></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Steve Oesterle</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Steve Oesterle</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Address:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Amendment No.&nbsp;2 to the Sponsor Support Agreement] </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>d230641dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Roivant Sciences Announces Close of Business Combination with Montes Archimedes Acquisition Corp. and Concurrent PIPE Financing </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">-</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Roivant will begin trading on Nasdaq under the ticker &#147;ROIV&#148; later today </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">-</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">R&amp;D Day presentations from September 28th highlighting Roivant&#146;s pipeline and discovery platform
available on <U>Roivant&#146;s investor page</U> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BASEL, Switzerland, LONDON, NEW YORK, and BOSTON, October&nbsp;1, 2021 &#151; Roivant
Sciences, a biopharmaceutical company dedicated to improving the delivery of healthcare to patients, today announced that it has closed its business combination with Montes Archimedes Acquisition Corp. (Nasdaq: MAAC), a special purpose acquisition
company, as well as a concurrent PIPE financing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Outstanding shares and warrants of MAAC have been exchanged for newly issued Roivant shares and
warrants, which will begin trading on Nasdaq under the ticker symbols &#147;ROIV&#148; and &#147;ROIVW&#148; later today. At the close of this transaction on September&nbsp;30, 2021, Roivant&#146;s consolidated cash position is approximately
$2.5&nbsp;billion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Roivant was founded to address inefficiencies in the traditional pharma model. As we begin our life as a public company, we now
have the opportunity to accelerate that vision and create significant value for patients, shareholders, and society,&#148; said Matt Gline, Chief Executive Officer of Roivant Sciences. &#147;I would like to thank our new investors for their support
as we continue to advance transformational medicines and novel modalities.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the company announced that Richard Pulik has joined Roivant
as Chief Financial Officer. Mr.&nbsp;Pulik brings over twenty years of industry experience. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to joining Roivant, Mr.&nbsp;Pulik was the Global Head
of Business Development&nbsp;&amp; Licensing and Portfolio Management, Oncology at Novartis and a member of Novartis&#146;s Innovation Management Board and the Novartis Oncology Leadership Team. Mr.&nbsp;Pulik joined Novartis in 2012 as a Senior
Director, Mergers&nbsp;&amp; Acquisitions based in Basel, Switzerland. Earlier in his career Mr.&nbsp;Pulik worked at Bank of America Merrill Lynch, Monitor Group and UBS Investment Bank, focusing on mergers and acquisitions and strategy in the
healthcare sector. Mr.&nbsp;Pulik received a B.S. in Finance from The Wharton School and a B.A. in Economics and International Relations at the University of Pennsylvania in 2001. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;I am humbled to join a company that has accomplished so much over the last seven years,&#148; said Mr.&nbsp;Pulik. &#147;I look forward to working with
its leadership to create a next-generation biopharma company that develops meaningful medicines for patients around the world.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Roivant R&amp;D
Day </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Roivant held a virtual R&amp;D Day on the afternoon of September 28th highlighting the company&#146;s drug discovery platform and recent clinical
milestones. Recordings of R&amp;D Day presentations and corresponding slides are available at <U>https://investor.roivant.com/news-events/events</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Advisors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC served as a
financial advisor and capital markets advisor to Roivant and as a lead placement agent for the PIPE. SVB Leerink LLC served as a capital markets advisor to Roivant and as a lead placement agent for the PIPE. Goldman Sachs&nbsp;&amp; Co. LLC served
as a financial advisor to Roivant. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Cowen and Company, LLC served as a financial advisor and capital markets advisor to Roivant. Citigroup Global Markets Inc. served as a placement agent for the PIPE. Truist Securities, Inc. served
as a capital markets advisor to Roivant and as a placement agent for the PIPE.&nbsp;Davis Polk&nbsp;&amp; Wardwell LLP acted as legal counsel to Roivant. Kirkland&nbsp;&amp; Ellis LLP acted as legal counsel to MAAC. Okapi Partners served as the
proxy solicitor for MAAC. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Roivant Sciences </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Roivant&#146;s mission is to improve the delivery of healthcare to patients by treating every inefficiency as an opportunity. Roivant develops transformative
medicines faster by building technologies and developing talent in creative ways, leveraging the Roivant platform to launch &#145;Vants&#146; &#150; nimble and focused biopharmaceutical and health technology companies. For more information, please
visit&nbsp;<U>www.roivant.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains forward-looking statements. Statements in this press release may include statements that are not historical facts and are
considered forward-looking within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;),
which are usually identified by the use of words such as &#147;anticipate,&#148; &#147;believe,&#148; &#147;continue,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;intends,&#148; &#147;may,&#148; &#147;might,&#148;
&#147;plan,&#148; &#147;possible,&#148; &#147;potential,&#148; &#147;predict,&#148; &#147;project,&#148; &#147;should,&#148; &#147;would&#148; and variations of such words or similar expressions. The words may identify forward-looking statements,
but the absence of these words does not mean that a statement is not forward-looking. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section&nbsp;27A of the
Securities Act and Section&nbsp;21E of the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our forward-looking statements include, but are not limited to, statements regarding our or our
management team&#146;s expectations, hopes, beliefs, intentions or strategies regarding the future, and statements that are not historical facts, including statements about the clinical and therapeutic potential of our product candidates and the
availability and success of topline results from our ongoing clinical trials and preclinical studies. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any
underlying assumptions, are forward-looking statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we believe that our plans, intentions, expectations and strategies as reflected in or
suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the
forward-looking statements and will be affected by a number of risks, uncertainties and assumptions, including, but not limited to, those risks set forth in Item 1A &#147;Risk Factors&#148; of our Quarterly Report on Form <FONT
STYLE="white-space:nowrap">10-Q</FONT> filed with the U.S. Securities and Exchange Commission on September&nbsp;21, 2021. Moreover, we operate in a very competitive and rapidly changing environment in which new risks emerge from time to time. These
forward-looking statements are based upon the current expectations and beliefs of our management as of the date of this press release, and are subject to certain risks and uncertainties that could cause actual results to differ materially from those
described in the forward-looking statements. Except as required by applicable law, we assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contacts: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Investors </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Roivant Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(646) <FONT STYLE="white-space:nowrap">495-5310</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>ir@roivant.com</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Media </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Paul Davis </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>paul.davis@roivant.com </U></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>ck0001635088-20210928.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20210621.2 -->
<!-- Creation date: 10/1/2021 4:10:32 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2020-01-31"
  xmlns:ck0001635088="http://roivant.com/20210928"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"

  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://roivant.com/20210928"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2020-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />

    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" namespace="http://fasb.org/us-gaap/2020-01-31" />
    <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" namespace="http://fasb.org/us-types/2020-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ck0001635088-20210928_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ck0001635088-20210928_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ck0001635088-20210928_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="ck0001635088_DocumentAndEntityInformationTable" name="DocumentAndEntityInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="ck0001635088_DocumentAndEntityInformationLineItems" name="DocumentAndEntityInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>ck0001635088-20210928_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20210621.2 -->
<!-- Creation date: 10/1/2021 4:10:34 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="ck0001635088-20210928.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="ck0001635088-20210928.xsd#ck0001635088_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="ck0001635088_DocumentAndEntityInformationTable" />
    <link:loc xlink:href="ck0001635088-20210928.xsd#ck0001635088_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="ck0001635088_DocumentAndEntityInformationLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="ck0001635088_DocumentAndEntityInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ck0001635088_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_WarrantMember" order="25" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="27.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="28.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="29.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="34.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="35.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="36.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="37.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="38.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="39.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="40.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="41.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine3" order="42.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="43.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="44.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCountry" order="45.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="46.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="47.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="48.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="49.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="50.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="51.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="52.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="53.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="54.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="55.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="56.001" priority="2" use="optional" />
  </link:definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>ck0001635088-20210928_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20210621.2 -->
<!-- Creation date: 10/1/2021 4:10:32 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Three</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Three</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Country</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:loc xlink:href="ck0001635088-20210928.xsd#ck0001635088_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="ck0001635088_DocumentAndEntityInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001635088_DocumentAndEntityInformationTable" xlink:to="ck0001635088_DocumentAndEntityInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="ck0001635088_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="ck0001635088_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Table]</link:label>
    <link:loc xlink:href="ck0001635088-20210928.xsd#ck0001635088_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="ck0001635088_DocumentAndEntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="ck0001635088_DocumentAndEntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="ck0001635088_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="ck0001635088_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_WarrantMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Warrant [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_WarrantMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant [Member]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>ck0001635088-20210928_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20210621.2 -->
<!-- Creation date: 10/1/2021 4:10:33 PM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="ck0001635088-20210928.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="ck0001635088-20210928.xsd#ck0001635088_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="ck0001635088_DocumentAndEntityInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="ck0001635088_DocumentAndEntityInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="ck0001635088-20210928.xsd#ck0001635088_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="ck0001635088_DocumentAndEntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationTable" xlink:to="ck0001635088_DocumentAndEntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember" xlink:type="locator" xlink:label="us-gaap_WarrantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_WarrantMember" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine3" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCountry" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="48.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="49.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="50.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="51.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="52.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="53.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="54.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="55.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ck0001635088_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="56.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d230641d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ck0001635088-20210928.xsd" xlink:type="simple"/>
    <context id="duration_2021-09-28_to_2021-09-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001635088</identifier>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="duration_2021-09-28_to_2021-09-28_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001635088</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <context id="duration_2021-09-28_to_2021-09-28_us-gaap-StatementClassOfStockAxis_us-gaap-WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001635088</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-28</startDate>
            <endDate>2021-09-28</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2021-09-28_to_2021-09-28">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2021-09-28_to_2021-09-28"
      id="Hidden_dei_EntityCentralIndexKey">0001635088</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="duration_2021-09-28_to_2021-09-28"
      id="Hidden_dei_CurrentFiscalYearEndDate_duration_2021-09-28_to_2021-09-28">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="duration_2021-09-28_to_2021-09-28">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2021-09-28_to_2021-09-28">2021-09-28</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2021-09-28_to_2021-09-28">Roivant Sciences Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2021-09-28_to_2021-09-28">D0</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2021-09-28_to_2021-09-28">001-40782</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2021-09-28_to_2021-09-28">98-1173944</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2021-09-28_to_2021-09-28">Suite 1</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2021-09-28_to_2021-09-28">3rd Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="duration_2021-09-28_to_2021-09-28">11-12 St. James&#x2019;s Square</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="duration_2021-09-28_to_2021-09-28">London</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="duration_2021-09-28_to_2021-09-28">SW1Y 4LB</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="duration_2021-09-28_to_2021-09-28">GB</dei:EntityAddressCountry>
    <dei:CityAreaCode contextRef="duration_2021-09-28_to_2021-09-28">44 207</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2021-09-28_to_2021-09-28">400 3347</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2021-09-28_to_2021-09-28">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2021-09-28_to_2021-09-28">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2021-09-28_to_2021-09-28">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2021-09-28_to_2021-09-28">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2021-09-28_to_2021-09-28_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">Common Shares, $0.0000000341740141 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2021-09-28_to_2021-09-28_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">ROIV</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2021-09-28_to_2021-09-28_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2021-09-28_to_2021-09-28_us-gaap-StatementClassOfStockAxis_us-gaap-WarrantMember">Redeemable warrants, each whole warrant exercisable for one Common Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2021-09-28_to_2021-09-28_us-gaap-StatementClassOfStockAxis_us-gaap-WarrantMember">ROIVW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2021-09-28_to_2021-09-28_us-gaap-StatementClassOfStockAxis_us-gaap-WarrantMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2021-09-28_to_2021-09-28">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2021-09-28_to_2021-09-28">true</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140559687032968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 28, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ck0001635088_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001635088<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--03-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 28,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Roivant Sciences Ltd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">D0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40782<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1173944<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Suite 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">3rd Floor<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">11-12 St. James&#8217;s Square<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">London<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">SW1Y 4LB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">GB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">44 207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">400 3347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ck0001635088_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Shares, $0.0000000341740141 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ROIV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ck0001635088_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Redeemable warrants, each whole warrant exercisable for one Common Share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ROIVW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ck0001635088_DocumentAndEntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ck0001635088_DocumentAndEntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ck0001635088_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M[9X&-7=1#K5L#7 R<V]E9C7\*J&=O;A680&3; G/(G*366F?R22KWC;,VMG
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M[0_;P<ZIH3N!?<M=GC$D$0M0\HZ&(*RK0\WJQJJ\/$B<*VM56E[&@D.R= _
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M J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ @D%!4Y>*NQS
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M"Q4&L&]R( DNR94;4EWI>::W=Y-[2:AU[D&P]_ :C1W-CQ^W_ %02P,$%
M  @ @D%!4R0>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!D#IT8;*>
M+7_OR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2
M*+I!V#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+B
MRTR6HJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#
M!!0    ( ()!05-ED'F2&0$  ,\#   3    6T-O;G1E;G1?5'EP97-=+GAM
M;*V334[#,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL
M>-Z\SYZ7K-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE
M@U#!$WBJ*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J
M1*BY<]!@9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;
M&@4ZJ+WCEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=
M560C2&2FKW@ALO7L^T%.6X.^D<WC_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^Q
MO-9.&G_FB^$_7G\!4$L! A0#%     @ @D%!4P=!36*!    L0   !
M         ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " ""04%3
M1C61'>T    K @  $0              @ &O    9&]C4')O<',O8V]R92YX
M;6Q02P$"% ,4    " ""04%3F5R<(Q &  "<)P  $P              @ '+
M 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( ()!05,ZCO,?* 4
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M2P$"% ,4    " ""04%3)!Z;HJT   #X 0  &@              @ &;$@
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " ""04%399!Y
MDAD!  #/ P  $P              @ & $P  6T-O;G1E;G1?5'EP97-=+GAM
7;%!+!08     "0 ) #X"  #*%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d230641d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d230641d8k.htm">d230641d8k.htm</File>
    <File>ck0001635088-20210928.xsd</File>
    <File>ck0001635088-20210928_def.xml</File>
    <File>ck0001635088-20210928_lab.xml</File>
    <File>ck0001635088-20210928_pre.xml</File>
    <File>d230641dex101.htm</File>
    <File>d230641dex31.htm</File>
    <File>d230641dex991.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d230641d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "ck0001635088-20210928_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "d230641d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ck0001635088-20210928_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ck0001635088-20210928_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ck0001635088-20210928.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 33,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 2,
   "nsprefix": "ck0001635088",
   "nsuri": "http://roivant.com/20210928",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d230641d8k.htm",
      "contextRef": "duration_2021-09-28_to_2021-09-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d230641d8k.htm",
      "contextRef": "duration_2021-09-28_to_2021-09-28",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "ck0001635088_DocumentAndEntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Line Items]",
        "terseLabel": "Document And Entity Information [Line Items]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationLineItems",
     "nsuri": "http://roivant.com/20210928",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "ck0001635088_DocumentAndEntityInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Table]",
        "terseLabel": "Document And Entity Information [Table]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationTable",
     "nsuri": "http://roivant.com/20210928",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three",
        "terseLabel": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "terseLabel": "Warrant [Member]"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://roivant.com//20210928/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-21-288885-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-21-288885-xbrl.zip
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M6%V"4P(^-:&V><<O#!@JX%688X+N@)\1.$_YJX1;E;PZ>>'U7U!+ P04
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M0\D_S.?FHT0=0DMB-B#%]D7:B'L?*I+(91DHUX&L$*25K.7NFD19]@<R<6"
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M S:MW@5;B=,!WYNG[;,SYI]Y=EP?^0]02P,$%     @ @D%!4R8*<T)&'0
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M2I/<7W4QWRK,6X%EY,63HKU_=OSO[P2)CGR=?7R/TP-?A,OEZET Q"7"+\"
M/:4JH'\1W8=\H/(SB\G)2?<F]+_(F8<\3M]G 6-3;?1?F3<@:;32N9J([$M0
M04SZ7.F&L*D$4[YY^?2=,,P329W%30")\^D[P>#3BIPB(A]-W-P2!]A]B#C
M<11@;(21X9SX.M,,(WX&-F2Z+GHAO<L5@>T!Y."D8S*6XBJ>8(AEABE?JDC
M1CPRIZ5,#JRQ39:/8&8G+UMIW 3IZ-6^3H>Y/C ;[.8,CUQAN8(>$$15M5DR
M9-FISL6Q,?"2=<^-7GOD6I$<)^@R@HW#7CD*#3-9EKJY7,R-\%X/T#7]'R5
MN%,2('Q,= %1CFX@LPH05RG-\J5JA E0) N9CY5OD=!1K40QW0IP9&L>\'8W
M;C*X^KRL5C0X5SC'R:\X3(W4'0%\\$:R2ZZ@'] YC7Q,DE%?U]IA8[SG+: R
M4*;:(;@QI-;:I&E(+4^^M76HX/HBA=\<]WT>$EC8WO7*@;ZWRU-,39"M#/KQ
M!]"*I:S"IDN<@E_ES,HA@\T!LS*\HG.%H0$8'._O2TU07X1"=G[:TW_VW8)F
MUX4<2-T"<7/5U</>B//C#\];-'A\>M$_>_NQ>W'6_X.<GEWTR&/+K#,P28LG
MXEL-<R*^0DI/0I--K&=L-O;M6_WD[:.,08E@7W:=8M OMXQ@8BC0>(Q2!J21
MJ=2B4012R(<7PT0!>2N%;8<@I;1LV\R-^<8UZ&8-T@FTO/N (@3TM/0GL,Y
MJ^R_$F[E9%?(60;^AZ.CKNM= ="E2,83O024WV!#X*'J;(FZ@!.M_'!>%5=H
M*ZAD"-X3IQ)$>W\"D)$/IN,@&>K*SIH%"B:J9!^AG[SDERAV<;*R1:%%0NUD
M9'&R'%PU KMWYL<BW3MO8>M2R'WC?:CUHB,%]!<"+!GFL++9.4,$^[#KF5%=
MH#E<9@O5E2YSA0%RIN7[4(#(=K9EEJ%2VJ-0;F:T^!V9X72YKS]5W L "N?E
MERR<UQ;9)L<2NU^:]GUSUG_;ZU>[9R<G1^>#7L=]^+K3OIY7FM0E^B-HEN5L
MY;(;<PQBPM)9K>'52GRN_&C/E8.]2<Z:9?;PA &6CPI@,U="1=ZB#\!UV?[1
M6#+M2AE"NJMKL_-$ KEB9<HY2 N\7,6<UR%=.L-"5/31@"UA/2&]PN]#/M6'
M*$).ASP$ZROU?/*RD QF(E)"IA(5.0V946B/"J2#=ECP@0'BM,+2'A-B$426
MN^8V'32]^!9/M]G+5M+!H9/VA,R<(#)G^OJ8%/$5@G>W!"@)0=Y]H/,%^882
M<FHL8;"F2Z;R'*3%D?Z51,PTV#-#D<ULJ$I>@ZT$+:<T!-GD6V8X/83&F=)W
M;YC:XTC7^>/$!>D)[VB,!J\"8SB)TSF;C5]N3\3WJ(RJ9TE:*6 CWDX.VJ&\
M^P]5)FI93+6#7&R!+@<X"C.AF$J=VU5XT^-M\B+"L$>^_$%OEALJ!MYPW@UX
M!-JMT0D5?'G/Q>G]SKG[-X*\!=P\)Y=XC1$"/V0 *B,C>)O5D(//9LY?*Z)
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M0(D1#)T( AHPWK2NP:"C&$D0/0:*A7:,5=%EL)G]"BP@1+I?V$V0+*@=D!.
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M%G8)J/=RZR_G6D>K=O- Z2OE;$#_)9^JUR7E=\1IX"1YTF!^09=*WZYM@''
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MC6^:/,0 >V>Q9[!/+O1OF(\>7"GT;"8F]=@::UKP"JP*:MX5!9!U4Y<QVG>
M8Y8LMTW*!^1&61],8=-('=^'UJ../57I?7>]3Z12:1SZ!6 +U>*Q4NGDZ%@1
M,"Z8A3R!SJ^V\VWV2@$5^YY.O;87Z/MTCI6I9TGA6[2R6/<2&N0EM7?J9(2N
M@HZ0+L28&JW$[1@LP35F&P2U7]C4>JB<2)VT 0;FAFI<I:@$5X8^W 4%@ 7-
ML'G441B8.7I T$@:87R"=3KD*LB>7M!NC0!_UH:&]DE+TQSD?T/I@-H+[ M$
M$,P-FS=%CH"=?Y#= SC"9UV7 UOW%7 (VF1A#. *7]TESZ0)A/(097J>K8QX
M?MUD\ZN7^$!* 7')RK99@E.SA3;U^R?Z;",MVD%.CA"3DJA*L7%P-XCJD$AA
M..D,+4+<<N2-LJ*97F;]AJX$Z^20#D8.=Z,=$GY<0%H^]?X1*_ABON<Z.$_#
M]H/QBO:#!9]A"\<HL3.U'_;9JG)(>=H.<L\@=DA![%*ZNC ,;@G;#V)5D$I<
M!B3FX<=;_%$JTL\2_3PB\X0744=UB*\)#B]IE\=P(JVP73_ZX TZ:.1O #8;
M%=.'301^R@M^0X0"DAJ5G5J#[V-D0,=?O:BO8:"@";DIV@MB.:S?V!9!'51=
M-M,'$7XK_,V0WN?J6X>I;SV0;S6:0'ZOJ76[C%KI6Q]5X*=^C> C  0#=8Z?
M4)M+4L$..!BG/NH89I-L!G(O]HC 7A2LD/$^I.Z';(\@:29KN'?NF'A=_(X=
M$\M:)+9K/B@EFP_"R\?'X?7Y0]3O?K@S.SP^5$? K<;G*L+@6D-KUK0NN^C5
M"]$I,)$75L65A[)GJ:YPX;?;-K2LTEPYH;FDUF)TQ*1_KC4^G?=@QC?)&6/7
MXR?Z";OX84=^9].3=1T'X6E@H*"S5J_7N@0N;^>;"E8? I'Q)?6\>IH#]T!]
M\->R!+(A[)_3'$OE>]KCN[<O'\EBFK -66<S6YP'_A(:+MY7P_.YXH=IN"<]
MX[XJ/A=\D&>?#+O/#74<SQ74#\Z"N3E^SSK2_0;N;@$KZN-6BR>RH2G\,$#^
M5Q>P$*=CO#8B< !(.WW'Q-_I)PE2>/O\PM?/ F\O6V#?75;MU,X;EUH=7];^
MN&IT&_1E0;56IYV"W13L/A&P._N6FY_3'E.TNU3%SPK0U492#,/.!\!T+?Q"
M@3@W*69+,5N*V5+,MCMF:U=[#?PFQ>X?5]4.B+O:;O2J%_A-="E42Z%:"M52
MJ)9"M12JI5 MA6HI5'MDJ-9H=AL@HFX*S%)@]NC +/G-T3^G.9;>W!>7'3YC
M7+9*PS^,AZU3<NG[?2ZZ.AA@._?)=A]G7C<B18(I$DR18(H$4R28(L&?"@DN
M_+<B/Z=%_MI@<(V24SR8XL$4#Z9X\!G&]A0//G4-I7CPV>'!7^/(]I=&@X]_
M9)MBP10+IE@PQ8(I%DRQ8(H%GRP63/[?P3^G.?[:4'"5AE,DF"+!=4@0TE.K
M_A4NGO<N+RK_!U!+ P04    " ""04%3\0E"2QZB  !.KP4 $    &0R,S V
M-#%D97@S,2YH=&WLO>MRV\:V+OI?57H'5-:9NZ0JVK%DQW%B3U?)EI)H'U^T
M)24Y<Z^:/T"@*78, IRX2.9Z^C-N?0-!2;:DF((P:]6*3(*-1F/TZ''YQC=>
M_7;Z_MWK5[\=[.V_WMQX=7IX^N[@]<'_]^CIXYU7W_._X./OY?OHU9N/^_^*
MWOSZ]N.[C\?__.[/WPY/#[Y['6UNP$5O55ZK\O6K_<,_HI/3?[T[^.=W%SJM
MIS^_>/R#SK^+XDR?Y?_\+E.3^CL:Z\A<-HO+,YT_JHOYST_F]<M(_CTNZKJ8
M\4>3(J\?5?I_U,\[[M^3>*:SQ<^G>J:JZ(.ZB(Z+60QWVGMW^.N'?WY7ZK,I
MW.K5F]<'GZ=ZK.L(GBIZ]?V;UZ^^/\+'ZIK SNXMSB"A):$I[+T_^+!_L!_M
M?=B/C@].3O=.X1]O_G7PZ-W>GR??:E(??[%W[GX==W7CXX^'?^Q].(U.WAX>
M?'A[<+*Y\>YT__&WF,Q>6LQKE49%'ITH^&LV5N7_RL?5_.73)Z-H]\DN2DPP
M(^]N+[P)K9;>[U[S@/*"OX<- D\IVP4V OW?JWE4U8M,A4^L9DOCX4?S^$P]
M&I<J_O1HK"9%J7Z.LXMX4>&^>O7;<71R^']AHD^_,T/2=OWYOWZB_WT7_7FX
M?_K;/[_;>?+D'W8]WAY\.#TX_KOW\LY7R,ZKWU^?[KUY=Q"!]+[]"+/^<(H;
MZ/?779O(NQ=*3VMVE[XJ?"E\H[<'[]Z='.V]/?SPZS^_>_(=_?MH;W_?_#M8
MSS<?C_</CNESF0-_\@A>PKN]HY.#G\T?ESYY6ZJ75@+?$TWQ^+7\L6\F\NP?
ML%#?G^Z[+_Z0'_.3NAF;"\/?OWAQW0%VPP%6_7WES^'_'?.UQV;5/!G7>:53
MD/'S0J?1M5?M!;[.[OO;M[QRAG+%=:^[A9% EE'(X(/=]KLV2S(NRE251EQW
M'C\!N8BJ(H-5^:\G]#_:($>P<KP7KC5M6GLG3;>V_B2U[?O#SO.>].EW*U1]
MA^K8\3Y"O4//C\JP5I]KF&(*:_7S(_/AEQP)N&:'J/V.C@_@7#[\^,%HDJ]Y
MK1\^_GF\=[1T.=S#7!N^F>[KEVV89]?[8<>-.C:7MSS>2_KMX/#7WTYA_X=:
MP7WLR^B5ESR[P[V]4K9\>6J=S%'G870W$K7S^&O%9PT?9E]-=*YK7>3539_J
MVEJS)?_/KB'X;97V91(?**6U%.UU5)LGO^V!,[..ZO+'05W>'W6YVR=U>51<
MJ#*JB^BPJAH5G4SC4GTSQ?GCC15G[X7O:?^$KYA$]51%;XO9/,X7*(M'39E,
MXTI%NJX&D5QWD7S6)Y$\QM=>17MU'2=3G9^A. X2N.82^$.?)/#5+Q\QUBQQ
MS*FNU:-J'B?JY[RX*&.8YKLB^?3H]_FK[_'"KS9E;RJ6/PUB>=6;?-XGL7P;
M9UE%B8=OJ@UW=@:YN^I5_=@GN?NE*"=*UTVIT%#\QL*W.PC?5>_K19^$C\0M
M>JO*6D]T$M>#Z*VSZ/W4)]'[I8P3C&+'V;=6>D^'</;*</:W]!/>O#X^^/7P
MY/28LH (,%C? #<*T1#AOB^*=.=)GS3IL3K35<V!QO<$F;K/NK3_PM>K=+01
M/I5&OQ59"E*X-ZZ*K*E5]/$B5^4WD\2;)ZG[+XF]RO2=EG%>35@->E+YC8W+
M00RO%L->Y?Q(#&>ZJL"WZ9LH#G[.W?@Y>^].#UI>3O1V[^CP=._=6CH[SP=G
MYQZIUU[EKRV>9R]#E^=M/-=UG'TSG?I\.-ZOE+]>9:__B$L=U^9L7SLPQ2T(
MY'#(W\TAOW_XQ^'^P8?]$ZHZE./]\/^N;8G#<,K?*RW;*S#&OCZ'=Y2G]UF/
M]E_D>H7#L(;EB:JC/7Q?T5%93'3][61P0$9>+8.]@F.\5_6T2-&R/(H7,QAG
M$+WU?5D[O8)CB".M_X><FWLL=X/[<C?NR_N#@]/##[^>8(3R_<'[-P?'ZPG$
M>#%X+?='A^[V"HBQE^=-G$6_JER5\-_W2M4Z/_MV]N.+X1"_4@![!<8XF:M$
M#Q)XOR2P5R",8_6?1E=$3Z'200[ODQSV"H7QH:AUH@9Y6]\WM-NKM/2O^ASS
M?RQV49RGT5Z2J.K;:;RA?/5J"?SAL;_\X:OHC60>%54]A],8PXE1@8B)/%%9
M9G/8K3/Z7@DL_#^DA*1?]9'($Q>CGYR7@8S)CWYZ\I5,F:O^7O7SD.CR[Z%:
M-,^]'DIAMU?98CEU09E]*&8Z)]56T2',Y3#1FZ;2^7 :K[U4]BJA?)"II"Z+
M7"?145R"A.HY'[HHF"<J:4I=+Z*X7ALO>7==B[?63$I[E7+^/TU1-K-!#.^?
M&/8K_3R-=3E7907Z$0GR2D4(G'42RW6MY%HOL7S:JXS>'P7*'+)"'2NJ:OV6
MM,N#!%Y/ GN5TK.PQ'TU0\,QCD F%4ID'!T5V3>K?!F$\7K"V*OLGJC#\2+Z
MWX7.:ZGXK[X]<=GN#X,T7D<:>Y7C.\RK&GP7BFM/$*S]>?'-Y&]=RP763/YZ
ME?,[5G-0>?![FTMY6Y3SHHSA?.; XR".ZRV.O:I,W4O_*IHR-_IP3?)Z@RA>
M3Q1[E9#YL]1UK=;#:5[72I8UD[]>I5[V=:F2NBBI-%_E*4(>UBJ6>'-\6'_+
M7$*Q:4O-W7;0VC\\/GA[^O&8:_0__O++X=LUK7/9'>I<[IF&[57:D)+;XO58
M;7N/U>F#D,!>90P_- 3M&>3OWLC?LUZE!M]F<56I:A# >R2 O<H,GJIRAM+W
M<3(1].,@A_=$#GN5%"0BQAR#WM]>_@:<[;7DKU=IP&,U*\[C;#T4X"" UQ+
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MFQN5AI6.2XPH)5PUA8'*BYSA?%Y4:05@W@28.,_'*]$WB3J%4:L&7@)MGEO
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MX6RRB.8Z[EZP1,-#H=5YJ1$;%>>?),,/^Y]I-SR<_#D>74LJP1TT;R6 <F(
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MRU/C#4/J C(1J2UL4V,/;?(&]6RF4@T><+:0,A%3S(&E-M@OUCCF]O@9JZ3
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M6=$5=^TH7<9GU,[W4+$6!_2K $TNL1G;D-2/,],]+Q0U!X!I='#S\@UQRS%
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MY5K%FQ#F$.>53LA3Y7XZQ%KE_)*1!:TX-8XV# Y+OQDYUV#) ^"4D3-GN@S
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M?I^N$:$S:8VML?Q:P;XEX]7E,-KU;6CNP45J(H?#W/=.[2W@.^_-M8QFGQ'
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M,6[CRIEP]%G&_*,T:N98&$!0SVI:7. HTUA8.^G3Q#!5LYJSB%<SL'!Q>@
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M^U-2.4,'DH<0.CM935=H.;,X7F7XL!"Z,@[(3%M$B*!AVB$'0N*WJY>#LO2
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M,1DOR7M$_#S"5S9U -^QECC=52WANL04E '+!(U8/D6_+4M3$RAGZ#4WL(/
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MJTAXI2\#[V1_[Y0"P,PP:2WXNYQ)#&%/P<MY?,B^N>(?*B(\4[PQ(EMGX<G
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MQ(%AQ^AX QRLIE/CF0JM_%@;-F%OW^Y&WF(*DO]E**5DO1V^V@>'[E2:%/P
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MMQFW& ;)E2Q/^LI?Y%$ICMZS+=B&DF9HJ;X3**3.>L5V)1;TU'F7J:0>?]Y
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MD"]4P?(3^8MZ^#ZEITFYH,#)U-<K/WZCFN2G38KD,TXKB,7V:1)N66O6=2Z
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M,FUUQ==A#G]K5Z#]>["MTAQI1\"[+M:4;::F$*8BX4$!\-8ONL=1$K/!OOQ
M2SHUA!$P'L[Y;*O:3TGG(9N33TRROS?*7U(*=<FH&=.$UT:^7$SU(C!8L^Z$
MWR/+]]3Z!DSB1\^GK7J#K?K\7FQ5$9*J!EEJERA(1UYWX%?;O[1+'2<5;M2E
M!^GAK?AF.W7#+ATG&2K'M_&T2^_I+OUI>W?IZ[S!O%)>,@S,U]F+)P&YK">*
M/@4V[D%;]E;@,YKF[+.SXW2GWI?I?I5$?X+'VV2Y1';M&E]\]!("CC9+NDV3
M^WNPJ:<M<<M;XOGWV[LECCJXLK]S@^_7V1I'94!(9TD[YE)=S#,U83(LUBUZ
M>+W*E%D89@7K=BN/X,XJX"U.\_F(MQQU^E.!>:]:-')EES)'BW;=FE)029)E
M4!7I4&M&?-<=[L-D/L_K)8.>LZ7$15[)G%KF(!NJ2^)$'WC"V1VM-ME4BWYO
M(W2*W"UCI7<G4F5*<-R\4-\C,R /F?:DVR?+?4E.0$8<$Z]>X-4"GCQZJ/GO
M^Y>Z?[(Y=0_;]=WK_\"'__SP^[]^_7]02P,$%     @ @D%!4TYGC^69#@
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M,#DR."YX<V102P$"% ,4    " ""04%3R>"B\PT&   >/   '0
M    @ $P!   8VLP,# Q-C,U,#@X+3(P,C$P.3(X7V1E9BYX;6Q02P$"% ,4
M    " ""04%3[=0:P5,(  !D8@  '0              @ %X"@  8VLP,# Q
M-C,U,#@X+3(P,C$P.3(X7VQA8BYX;6Q02P$"% ,4    " ""04%39FQ'+LP%
M  "T0   '0              @ $&$P  8VLP,# Q-C,U,#@X+3(P,C$P.3(X
M7W!R92YX;6Q02P$"% ,4    " ""04%3)@IS0D8=   3K   #@
M    @ $-&0  9#(S,#8T,60X:RYH=&U02P$"% ,4    " ""04%3FJ@\#=D/
M  "Y@0  $0              @ %_-@  9#(S,#8T,61E>#$P,2YH=&U02P$"
M% ,4    " ""04%3\0E"2QZB  !.KP4 $               @ &'1@  9#(S
M,#8T,61E>#,Q+FAT;5!+ 0(4 Q0    ( ()!05-.9X_EF0X  +$N   1
M          "  =/H  !D,C,P-C0Q9&5X.3DQ+FAT;5!+!08     "  ( " "
(  ";]P     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
